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ABSTRACT OF THE DISSERTATION
SYNTHESIS OF AROMATIC MONOTHIOLS AND AROMATIC DITHIOLS
TO INCREASE THE FOLDING RATE AND YIELD OF
DISULFIDE CONTAINING PROTEINS
by
Amar S. Patel
Florida International University, 2010
Miami, Florida,
Professor Watson J. Lees, Major Professor
Most pharmaceutically relevant proteins and many extracellular proteins contain
disulfide bonds. Formation of the correct disulfide bonds is essential for stability in
almost all cases. Disulfide containing proteins can be rapidly and inexpensively
overexpressed in bacteria. However, the overexpressed proteins usually form aggregates
inside the bacteria, called inclusion bodies, which contains inactive and non-native
protein. To obtain native protein, inclusion bodies need to be isolated and resolubilized,
and then the resulting protein refolded in vitro. In vitro protein folding is aided by the
addition of a redox buffer, which is composed of a small molecule disulfide and/or a
small molecule thiol. The most commonly used redox buffer contains reduced and
oxidized glutathione. Recently, aliphatic dithiols and aromatic monothiols have been
employed as redox buffers. Aliphatic dithiols improved the yield of native protein as
compared to the aliphatic thiol, glutathione. Dithiols mimic the in vivo protein folding
catalyst, protein disulfide isomerase, which has two thiols per active site. Furthermore,
aromatic monothiols increased the folding rate and yield of lysozyme and RNase A
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relative to glutathione. By combining the beneficial properties of aliphatic dithiols and
aromatic monothiols, aromatic dithiols were designed and were expected to increase in
vitro protein folding rates and yields.
Aromatic monothiols (1-4) and their corresponding disulfides (5-8), two series of
ortho- and para-substituted ethylene glycol dithiols (9-15), and a series of aromatic
quaternary ammonium salt dithiols (16-17) were synthesized on a multigram scale.
Monothiols and disulfides (1-8) were utilized to fold lysozyme and bovine pancreatic
trypsin inhibitor. Dithiols (11-17) were tested for their ability to fold lysozyme. At pH 7.0
and pH 8.0, and high protein concentration (1 mg/mL), aromatic dithiols (16, 17) and a
monothiol (3) significantly enhanced the in vitro folding rate and yield of lysozyme
relative to the aliphatic thiol, glutathione. Additionally, aromatic dithiols (16, 17)
significantly enhance the folding yield as compared to the corresponding aromatic
monothiol (3). Thus, the folding rate and yield enhancements achieved in in vitro protein
folding at high protein concentration will decrease the volume of renaturation solution
required for large scale processes and consequently reduce processing time and cost.
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Chapter 1

Introduction
1.1 Introduction
Proteins are the most abundant organic molecules in living organisms. They occur
in every part of the cell and constitute about 50% of cellular dry weight. Proteins form
the fundamental basis of life.1 The human body contains approximately 100,000 different
types of proteins, and each protein has its own function, such as catalysis, transport and
storage of small molecules and ions, growth control, and mechanical support.
Furthermore, proteins perform regulatory roles including monitoring extracellular and
intracellular conditions, and passing information to other cellular components. One
striking feature is that most known enzymes are proteins. Enzymes are macromolecules
that catalyze most of the chemical reactions in biological systems, and can increase
reaction rates by many orders of magnitude.
Proteins are composed approximately 20 different amino acids, and each amino
acid is connected to another by a peptide bond to form a polypeptide chain.1 The structure
of proteins is divided into four levels (Figure 1):
a) Primary structure is the sequence of amino acids joined by peptide bonds to
form a polypeptide chain;
b) Secondary structure refers to the spatial arrangement of amino acids residues
that are nearby in the sequence, these arrangements are regular and give rise to
alpha helices and beta sheets;
c) Tertiary structure refers to the spatial arrangement of amino acids residues that
are far apart in the sequence and to the pattern of disulfide bonds;
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d) Quaternary structure refers to the spatial arrangement of polypeptide chains and
the nature of their interaction.

Figure 1. Diagrammatic representation of the stages of protein formation. a) Primary
structure, b) Secondary structure, c) Tertiary structure of myoglobin, and d) Quaternary
structure of hemoglobin. Figure from Griffiths, W., 1999.2
Proteins are initially synthesized as linear polypeptide chains that are eventually
extruded from ribosome. At this stage, the proteins are considered to be nonnative and
nonfunctional. In order to become native and functional, proteins have to shield their
exposed hydrophobic residues and adopt a precise tertiary structure. It is well known that
the primary amino acid sequence determines the tertiary structure of proteins, but how
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folding occurs to form native protein is still the subject of intense investigation. Many
experiments have been conducted to gain insight into how proteins efficiently acquire
their three dimensional structure.3 Additionally, an understanding of protein folding
would provide a basis for the design of proteins and help in structure prediction from the
amino acids sequence.
Although the amino acid sequence specifies the tertiary structure of proteins, the
formation of native disulfide bonds plays an important role in the biosynthesis of many
extracellular proteins including most pharmaceutically relevant proteins.4 The formation
of the correct disulfide bonds between cysteine residues is essential for stability and
activity in almost all cases. Disulfide bonds stabilize the native three dimensional
structure of proteins by lowering the entropy of the unfolded state and by forming
energetically favorable interactions in the native state.5 Failure to form the correct
disulfide bonds may lead to protein misfolding, aggregation, and degradation by
proteases which can result in various neurodegenerative diseases.6
1.2 Importance of protein folding
1.2.1 Protein misfolding diseases
Protein folding and unfolding are coupled to many significant events in the
functioning of a biological systems, including translocation of proteins across
membranes, secretion of extracellular proteins, protein trafficking, and the control and
regulation of the cell cycle.7 Many human diseases arise from the failure of a specific
peptide or protein to adopt or remain in its native functional conformational state, which
leads to protein aggregation. These pathological disorders are generally referred to as
protein misfolding diseases and recently, were grouped under the name of protein
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conformational disorders (PCDs).8 The diseases in this group include Alzheimer's
disease, transmissible spongiform encephalopathies, Hungtington disease, cystic fibrosis,
type II diabetes, mad cow disease, Parkinson’s disease, Crutzfeldt-Jacob disease, and
cancer.6,9-12 The characteristic feature of PCDs is a change in the secondary and/or
tertiary structure of a normal protein without any change in the primary structure. These
conformational changes may lead to various diseases by either the gain of toxic activity
or by the loss of biological activity (Figure 2).13,14

Figure 2. Schematic representation of protein misfolding which may results in diseases
from Soto, C., 2001.10
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1.2.2 Protein folding by recombinant technology
Recombinant DNA technology allows the large scale synthesis of proteins for
both research and industrial purposes. Recombinant technology, which was developed
from decades of basic research on the nature of DNA, has allowed the synthesis of many
useful proteins such as insulin and provided a vital tool for studying gene activity. 15 With
biotechnology, high value proteins can be overexpressed in bacteria in a rapid and
inexpensive way. However, overexpressed proteins, especially disulfide containing
proteins, can be deposited as insoluble inactive aggregates (inclusion bodies) in the host
cell. The protein within these aggregates is usually inactive and non-native. To obtain the
native protein, it is necessary to isolate the aggregates, resolubilize the protein, and fold
the protein in vitro (Figure 3).16 The formation of the correct disulfide bonds during in
vitro protein folding is the slowest and the rate-determining step.

Induction

Purification

Inclusion Bodies
(Inactive protein)

E.coli
1) Isolation
2) Solubilization

Inclusion Bodies
(Inactive protein)

Active Protein

3) In vitro folding

Figure 3. Protein expression by recombinant DNA technology.

The common process to recover native protein from inclusion bodies involves 3
steps:
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a) Isolation of inclusion bodies- Inclusion bodies have relatively high specific density,
and thus can be harvested after cell lysis by centrifugation at moderate rotor speeds.17
b) Inclusion bodies solubilization- Solubilization of inclusion bodies can be
accomplished using strong denaturants such as 6 M guanidium HCl (Gdn HCl) or 6-8
M urea, which disrupts noncovalent bonds between polypeptide chains.18 Two
reasons Gdn HCl preferred over urea are: First, Gdn HCl is a strong chaotroph, which
can solubilize strong sturdy inclusion bodies; Second, urea may decompose to give
cyanate ions, which can irreversibly modify the amino acids residues of the protein
especially upon long term incubation at alkaline pH.19 The isolated inclusion bodies
of cysteine containing proteins usually contain interchain disulfide bonds which
reduce solubility of the inclusion bodies.20 Thus, low molecular weight thiol reagents
are usually added in combination with chaotrophs to reduce the interchain disulfide
bonds by thiol/disulfide interchange reactions. Thiol reagents such as dithiothreitol,
dithioerythritol, glutathione, cysteine, cystamine, or 2-mercaptoethanol can be
employed. Furthermore, detergents have also been used to solubilize inclusion bodies.
Most commonly used detergents are sodium dodecyl sulfate (SDS) and n-cetyl
trimethylammonium bromide (CTAB).21
c) Refolding of solubilized protein- The refolding step should be optimized for each
protein in order to get the highest yield of active protein. The general procedure for
refolding involves the removal of denaturant, thereby allowing the polypeptide to
recover its native structure. Denaturant can be removed by several methods including
dilution, dialysis, diafiltration gel filtration, and immobilization on solid support. The
dilution method involves diluting the denatured protein solution into refolding buffer
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which reduces the chaotrope concentration and provides a suitable environment for
the protein to refold. Dilution has been used to fold many proteins such as antibody
fragments, interleukin 2, M-CSF, and pro-urokinase.22-25 The major drawback of the
dilution method is the requirement for large processing volumes which increases the
overall cost. In dialysis, the concentration of denaturant is reduced by dialyzing
against refolding buffer. As the concentration of chaotrope decreases, the protein
starts to refold. Dialysis membranes are semi-permeable membranes, which allow the
transport of small molecules across the membrane and retain the large molecules. The
process is driven by the osmotic pressure difference across the membrane. Examples
of proteins folded by dialysis are citrate synthase, chymotrypsinogen, and urokinase.
26-28

As the process of dialysis is controlled by osmotic pressure, dialysis may be too

slow to be employed in commercial scale production of proteins. As an alternative,
diafiltration can be used for removal of denaturant and refolding of proteins.
Diafiltration is a pressure driven process using ultrafiltration membranes of specific
membrane size which allows the transport of small molecule chaotrope across the
membrane while retaining the protein. Simultaneously, refolding buffer is added at
the same rate as solvent passes through the membrane. Examples of proteins folded
by diafiltration are prorennin and carbonic anhydrase.28,29
1.3 Background
1.3.1 Thiol/disulfide interchange reaction
Most pharmaceutically relevant proteins and many extracellular proteins contain
disulfide bonds. When these proteins are overexpressed in bacteria, they usually produce
inclusion bodies. To obtain these proteins in their biologically active form, it is necessary
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to resolubilize the inclusion bodies and then fold the protein in vitro. In in vitro protein
folding, a significant challenge is the formation of the correct disulfide bonds between
cysteine residues. Disulfide bonds are the only covalent bonds formed during folding and
their formation is usually slow and thus the rate determining step. Disulfide bond
formation involves thiol/disulfide interchange reactions as shown in scheme 1. The
mechanism involves the nucleophilic attack of a thiolate anion (R1S¯) on a disulfide bond
(R2SSR3), displacing one sulfur (R3S) of the disulfide bond and forming a new disulfide
bond (R1SSR2). R3S¯ acts as the leaving group and R2S acts as the center sulfur.5 As the
number of cysteine residues increases, the probability of forming non-native disulfide
bonds increases exponentially.
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S
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S

S

S
R3

R1

R3

Disulfide bond

S

R2

New disulfide bond

Leaving group

Scheme 1. Mechanism for thiol/disulfide interchange reaction
To enhance the in vitro folding rate of disulfide containing proteins, protein
catalysts and a limited number of small molecule thiols have been used.4,5,30-33 Protein
catalysts, such as protein disulfide isomerase (PDI), which is used in vivo, can increase in
vitro protein folding rates significantly. However, the use of PDI for in vitro folding is
impractical because of its high cost and the amount of PDI required to achieve significant
rate enhancements.31 Small molecule aliphatic thiols, such as glutathione (GSH),
cysteine, and dithiothreitol (DTT) are usually employed for in vitro protein folding.5,33 A
small molecule thiol is generally used in combination with a small molecule disulfide, to
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form a redox buffer, for example oxidized glutathione (GSSG) and reduced glutathione
(GSH). Although protein folding rates with small molecule thiols are slower than those
obtained with PDI, small molecule thiols are less expensive and can easily be removed
from the native protein. Recently, more efficient redox buffers containing aliphatic
dithiols, synthetic peptides, or aromatic monothiols have been employed as redox
buffers.32,34-38
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Protein
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S1
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S3

S3

S3

Protein

S1
R
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S3

R

Scheme 2. Role of redox buffer thiol in thiol/disulfide interchange reactions, where the
redox buffer thiol (R-S3) can act as 1) a nucleophile, 2) a center thiol, and 3) a leaving
group.39
The folding pathways of several disulfide containing proteins have been well
characterized.5,40-42 Each of these pathways involves multiple thiol/disulfide interchange
reactions between the protein and small molecule thiols and disulfides. Several factors
may influence the rate of formation of disulfide bonds, such as the concentration of the
thiolate anions, accessibility, proximity, and reactivity of the thiol group and disulfide
bonds.5,41 The concentration of the thiolate anion depends on several factors such as total
thiol concentration, the thiol pKa, and the solution pH.35 The thiol in its deprotonated
form can act as a nucleophile or a leaving group, and thiol in a disulfide can act as a
center thiol (Scheme 2).35 Disulfide bond formation can be inhibited by the burial of
reactive groups, such as protein thiol groups, protein disulfide bonds, and mixed disulfide
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bonds, in a stable tertiary structure. For instance, the burial of the disulfide bonds in
stable tertiary structures prevents their reduction and reshuffling. On the other hand, the
segregation of two protein thiols can inhibit the formation of a disulfide bond between
them. Thus, stable tertiary structures can inhibit the contacts between the thiolates and
disulfides and thereby affect their reactivity.
The thiol/disulfide interchange reaction can occur intramolecularly, that is within
the protein itself, or intermolecularly between the protein and the redox buffer.5 During
the in vitro folding of disulfide containing proteins, there are 8 possible types of the
thiol/disulfide interchange reaction that can occur. In the first four reactions (Figure 4, AD), the protein thiolate acts as a nucleophile, while the small molecule thiolate acts as a
nucleophile in the last four reactions (Figure 4, E-H). The thiolates can nucleophilically
attack one of several disulfides, a protein disulfide (Figure 4, A and E); a small molecule
disulfide (Figure 4, B and F); a mixed disulfide between a small molecule thiol and a
protein thiol at either the sulfur attached to the protein (Figure 4, C and G) or the small
molecule (Figure 4, D and H).
Moreover, the rates of almost all of the thiol/disulfide interchange reactions can
be increased by aromatic thiols compared to aliphatic thiols under standard conditions.
The reasons are that aromatic thiols are better nucleophiles, better leaving groups, and
better center thiols than aliphatic thiols such as glutathione at pH 7.0 or 7.7.43,44 Aromatic
thiolates are better nucleophiles than aliphatic thiolates with similar thiol pKa values.43
Moreover, the leaving group ability of thiols is inversely proportional to the thiol pKa.
Thus, aromatic thiols are better leaving group than glutathione as aromatic thiols have
lower thiol pKa values than glutathione.43
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Figure 4. Thiol/disulfide interchange reactions with a small molecule thiol (RSH) and a
small molecule disulfide (RSSR) that occur during in vitro protein folding.37
1.3.2 Protein disulfide isomerase
Protein disulfide isomerase (PDI), a 57 kDa protein, is a member of a large family
of dithiol/disulfide oxidoreductases, the thioredoxin superfamily.45 Protein disulfide
isomerase is found in a number of living organisms, such as fungi, plants, and animals. 46
Protein disulfide isomerase is constitutively expressed in many tissues and organs and
retained in the lumen of the endoplasmic reticulum in high concentrations. In the
endoplasmic reticulum, PDI catalyzes the formation, reduction, and isomerization of
disulfide bonds in newly synthesized proteins.47 Additionally, PDI also shows chaperone
activity, by preventing the aggregation of unfolded proteins, and is a member of two
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multimeric enzyme complexes, prolyl 4-hydroxylase and microsomal triglyceride transfer
protein.48-50
1.3.2.1 Structure of PDI

a
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233-235

349-369
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c

508

479

Figure 5. Domains of human PDI, numbering is for full length human PDI.51
Human PDI consists of 491 amino acids and has four distinct domains, a, b, b’,
and a’, plus a highly acidic C-terminal extension c and a 19-amino acid interdomain
linker between the b’ and a’ domains called x (Figure 5).51 The catalytic a and a’
domains are homologous to thioredoxin, and each domain contains an independent active
site. Each active site contains two cysteine molecules in the sequence Cys-Gly-His-Cys
(CGHC), which mediates PDI's acitivities.52 The b and b’ domains are similar in
sequence to each other but different from thioredoxin and redox inactive. The function of
b’ domain is to bind substrate proteins.53 The cationic c domain is not essential for
enzymatic activity and ends with a C-terminal endoplasmic reticulum retention signal
(KDEL in rat and human, HDEL in yeast).54,55 The crystal structure of human PDI is
unknown, although structures of individual a and b domains of human PDI have been
determined by NMR spectroscopy.56,57 These studies showed that not only the a domain
but also the b domain adopts the thioredoxin fold. However, the three dimensional
arrangement of the four thioredoxin domains and their respective functions in the
catalytic mechanism are still unknown.
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Figure 6. a, b, b’, and a’ domains of PDI are represented in magenta, cyan, yellow, and
red, respectively, and C-terminal extension is represented in green. The orientation of the
two structures differ by a 90° rotation around the horizontal axis. In the a and a’ domains,
the side chains of active site cysteines are revealed in space filling representation with the
sulfur atoms in yellow color. Figure from Tian, G. et al., 2006.58
Recently, Tian et al. have determined the crystal structure of full length yeast PDI
at 2.4 Å resolution, the first complete PDI structure.58 The crystal structure of PDI adopts
the shape of the letter "U" although in twisted form. The a and a’ domains lies on the end
of the "U" and the b and b’ domains form the base (Figure 6). The width and height of
the molecule "U" is ~80 Å and ~60 Å, respectively. According to the crystal structure,
each of the domains, a, a’, b, and b’, adopts the thioredoxin fold with minor changes
(Figure 7I). The prototypical thioredoxin fold consists of a five stranded β sheet with two
α helices on each side (Figure 7II).
In vivo, disulfide bond formation is catalyzed by PDI. Protein disulfide isomerase
contains two cysteine thiol groups (two cysteine separated by two amino acids, CXXC) in
each active site. One cysteine thiol is solvent exposed and the other thiol is buried. The
solvent exposed thiol has a low pKa value, 6.7, and is relatively reactive with disulfide
bonds compared to small molecule aliphatic thiols, such as glutathione. The other thiol
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has a high thiol pKa value and is buried inside the protein. However, the use of PDI for in
vitro folding of disulfide containing protein is limited because of its cost and low
catalytic activity (kcat = ~ 1 min -1).31

I

II

Figure 7. I) Structure of a, a’, b, and b’ domains of PDI. II) The typical thioredoxin fold,
green represents α helices, red represents β sheets, and red oval indicates the location of
active site. Figure from Tian, G. et al., 2006.58
1.3.2.2 Chaperone and anti-chaperone activity of PDI in the oxidative folding of
lysozyme
One of the most common problems faced in in vitro protein folding of lysozyme
is aggregation, which results from the low solubility of the unfolded protein or folding
intermediates.59 Aggregation is also a common phenomenon when disulfide containing
proteins are overexpressed in vivo. The folding efficiency depends on how the unfolded
denatured protein partitions between pathways leading to aggregation and pathways
leading to native protein. In vivo, foldases and molecular chaperones influence the
partitioning between productive and non-productive folding pathways.60 Foldases
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increase the folding rate by catalyzing the slow chemical steps such as disulfide
formation and proline isomerization.61,62 Molecular chaperones do not appreciably
increase the folding rate, but inhibit non-productive aggregation and misfolding by
binding to non-native proteins.60,63 In order to inhibit aggregation, molecular chaperones
must be present in stoichiometric excess as compared to the protein substrate, while
foldases (e.g. PDI) can function at catalytic concentrations. When the functions of
foldases and molecular chaperones become unbalanced, productive folding may be
disturbed leading to protein aggregation and misfolding. Apart from its role as a foldases,
PDI has two paradoxical roles in substrate aggregation. Protein disulfide isomerase can
function as a chaperone and inhibit aggregation, or under some conditions, PDI behaves
as an anti-chaperone and assist in the formation of aggregates.
Initially, during the folding of lysozyme, when PDI is present in substantial
stoichiometric excess, PDI can prevent the formation of lysozyme aggregation,
suggesting that very rapid disulfide formation can divert the denatured protein toward
productive folding (Figure 8).48 Furthermore, one of the characteristic features of
molecular chaperone involves the interaction of the chaperone’s nonspecific peptidebinding site with a denatured protein in a manner which inhibits protein aggregation. A
nonspecific peptide/protein binding site is present in PDI, which can act as a molecular
chaperone at high PDI concentrations and inhibit lysozyme aggregation.64-66
In contrast, under certain conditions, PDI aids in the formation of protein
aggregates, a behavior known as anti-chaperone activity.67,68 The anti-chaperone activity
of PDI may be attributed to the interaction between PDI and lysozyme aggregates, which
facilitates the intermolecular cross linking of additional lysozyme to the aggregate, even
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for molecules that were previously committed to folding (Figure 8). Intermolecular cross
linked aggregates between PDI and unfolded protein is usually seen when low
concentration of PDI is added to a solution of unfolded, reduced lysozyme.67 Thus, PDI
shows anti-chaperone like activity at low concentration and exhibits chaperone like
activity at high concentration suggesting the rationale for PDI's high concentration in vivo
and its low catalytic efficiency.

Chaperone

Anti-chaperone

Figure 8. Proposed model for the chaperone and anti-chaperone activity of PDI by Puig
et al., 1994.48 U indicates reduced, denatured lysozyme. Ia and If are denatured lysozyme
that are committed to aggregation and folding, respectively. N denotes native lysozyme
and P represents PDI.48

1.3.3 Role of Ero1p and glutathione in oxidative protein folding
Native disulfide bond formation is an essential step for the folding and stability of
many secreted proteins. The first step of the process is the oxidation of protein thiols to
form disulfide bonds, and the next step is the rearrangement of non-native disulfide bonds
to native ones.40,69 In vitro, oxidative protein folding is spontaneous but slow, taking from
hours to days.70 However, in vivo, oxidative protein folding is fast, which suggests that
disulfide bond formation and rearrangement is catalyzed by enzymes in living cells.71
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Protein disulfide bond formation in eukaryotic cells occurs in the lumen of the
endoplasmic reticulum (ER).72 The ER contains millimolar concentrations of reduced
glutathione (GSH) and oxidized glutathione (GSSG), although the exact concentrations
of both are unknown. The ratio of [GSH]/[GSSG] in the ER ranges from 1:1 to 3:1, while
in the cytosol, the ratio ranges from 30:1 to 100:1.73 The high concentration of GSH in
the cytosol disfavors the formation of protein disulfide bonds in the cytosol. On the
contrary, the more oxidizing conditions in the ER compared to the cytosol
thermodynamically favors the formation of protein disulfide bonds. The high
concentration of GSSG in the ER has led to the proposal that GSSG provides the
oxidizing equivalents that are required during protein disulfide bond formation in vivo.73
Over the past decade, the perception of the physiologically relevant mechanisms
for PDI oxidation in vivo has changed. Prior to 1998, GSSG was thought to oxidize PDI
in vivo, however, by the discovery and subsequent characterization of ER membrane
associated protein, Ero1p, this viewpoint has been changed.74 Now, it is believed that
Ero1p provides the oxidizing equivalents necessary for protein disulfide bond formation
to PDI.74-76 While screening temperature sensitive Saccharomyces cervisiae mutants for
conditional defects in export of secretory proteins from the ER in yeast, a novel gene
named Ero1 was identified.74,75 Furthermore, Ero1p driven oxidation of PDI can occur
independently of glutathione both in vivo and in vitro.74,77 Most importantly, Ero1p and
PDI form a mixed disulfide in vivo.78 In the ER lumen, flavin adenine dinucleotide (FAD)
bound Ero1p oxidizes PDI through a thiol/disulfide interchange reaction. In the absence
of Ero1p, PDI accumulates in its reduced form.77 Ero1p is not the direct oxidant of
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folding proteins, but relies on PDI to transfer oxidizing equivalents.77 Thus the oxidizing
equivalents are transferred via the protein relay: Ero1p to PDI to protein (Figure 9).
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Figure 9. The pathway of native disulfide bond formation in the ER of the lumen by PDI
via Ero1p.
Genetic evidence in yeast has shown that glutathione is not essential for disulfide
bond formation, but that glutathione functions as a net reductant in the ER.79 The role of
glutathione as a reductant was evident from studies in which the synthesis of GSH was
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prevented. While screening suppressors of the temperature sensitivity of the ero1-1
mutant, a deletion of GSH1, the first enzyme in the biosynthesis of glutathione, was
found to strongly suppress the ero1-1 phenotype.79 The absence of glutathione as a
reductant resulted in less reduction of oxidized PDI and proteins, thus, allowing a
compromised ero1-1 oxidation system to support growth of yeast. The oxidative protein
folding of carboxypeptidase Y (CPY), a five disulfide bond containing protein, proceeds
with normal kinetics in a Δgsh1 strain but is sensitive to oxidative stress, consistent with
the role of glutathione as a net reductant.79 Additionally, two more studies have shown
that glutathione has a crucial role in the isomerization of non-native disulfide bonds.80,81
These studies showed that when the glutathione level in the ER decreases, disulfide bond
formation increases. However, the increase in the disulfide bond formation is
accompanied by an increase in non-native disulfide bond formation. Furthermore, a
decrease in the levels of cytosolic GSH results in PDI becoming more oxidized, limiting
the ability of PDI to isomerizes non-native disulfide bonds. Thus, it suggests that, directly
or indirectly, GSH is involved in the isomerization of non-native disulfides.82
1.3.4 General pathway of protein folding
Numerous folding studies on model proteins, such as ribonuclease A (RNase A),
have been conducted to understand the mechanism of protein folding. Some proteins fold
directly without any intermediate, while others fold via one or more folding
intermediates. Four general types of protein folding pathways via intermediates were
proposed by Scheraga et al. (Figure 10) on the basis of oxidative protein folding studies
with RNase A.41 Terminology used to describe the covalent structure of disulfide
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Figure 10. Generic folding pathways for oxidative folding of a typical disulfide
containing protein as proposed by Scheraga et al., 2000.41
intermediates is as follows: A disulfide species refers to a protein with a specific pairing
of cysteines in its disulfide bonds, whereas a disulfide ensemble is any collection of
disulfide species. A des species is where the protein is missing only one native disulfide
bond, for example, the des[65-72] species of RNase A has three native disulfide bonds,
but lacks the 65-72 disulfide bond. The intermediates in the pathways are classified into
two groups, "unstructured precursor" where the protein has random disulfide bonds, and
"des species". It was assumed that only intermediates which have native-like structure,
such as des species are capable of folding to a native like structure (indicated by "N"
subscript). The "U" and "lu" subscripts represent that the corresponding species are
unfolded or locally unfolded, respectively.
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Pathway I is the simplest oxidative folding pathway, as it has no structured
intermediates. The native protein N regenerates directly from an unfolded precursor desU.
In pathway II, folded intermediate desN is formed and is not metastable; desN then is
oxidized directly to the native state. Pathway III involves the formation of a folded
intermediate desN which is metastable; desN preferentially oxidizes to the native protein.
The metastable intermediate must first undergo a local unfolding step deslu before
oxidizing to the native state. Pathway IV involves the formation of a folded metastable
species desN which preferentially reshuffles rather than being oxidized to the native
protein. Pathway IV is referred to a metastable dead end pathway. The rate determining
steps for pathways I and II are the formation of the structured species, while that for
pathway IV is the conformational unfolding of the metastable species. Pathway III is
intermediate between pathway II and IV; the rate determining step may be either the
formation of the structured intermediate or the local unfolding of the structured
intermediate, depending on the folding conditions.
1.3.5 Hen egg white lysozyme (HEWL)
1.3.5.1 General information
Lysozyme, an enzyme present in tears, mucus, other body secretions, and egg
whites, catalyzes the hydrolysis of the β (1-4) glycosidic linkage between Nacetylmuramic acid (NAM) and N-acetylglucosamine (NAG).1 Lysozyme functions as a
bactericidal agent or helps to dispose the bacteria after they have been killed by other
means.1 Lysozyme has been widely studied and is one of the most mechanistically well
characterized enzymes. In 1922, Alexander Fleming discovered lysozyme by accident in
his laboratory. Nasal mucus was dripped into a Petri dish with bacterial cultures by
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accident, and cells were lysed. He carefully observed this phenomenon and determined
the substance responsible for the lysis of the bacteria. Fleming discovered that the
antibacterial substance was an enzyme and he named it lysozyme, lyso- means capacity
to lyse bacteria and zyme- as it is an enzyme. The X-ray structure of HEWL was
elucidated by David Phillips in 1965. The three dimensional structure revealed that
lysozyme is roughly ellipsoidal in shape with the dimensions of 30 x 30 x 45 Å.

Cys64-Cys80
Cys76-Cys94

Cys30-Cys115
Cys6-Cys127

310 helix
Figure 11. Rasmol representation of native hen egg white lysozyme.42 (PDB id: 3A8Z)
Lysozyme is a monomeric protein of 14.6 kDa containing 129 amino acids and
eight cysteine residues forming four disulfide bonds. The four disulfide bonds occur
between residues Cys6-Cys127, Cys30-Cys115, Cys64-Cys80, and Cys76-Cys94 and
provide stability to the native structure of lysozyme.42 The disulfide bonds in native
lysozyme are denoted as [6-127], [30-115], [64-80], and [76-94]. Lysozyme is made up
of two domains, one consisting of four α-helices and a C-terminal 310 helix (called the αdomain), and one consisting of a triple-stranded antiparallel β-sheet, a 310 helix, and a
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long loop (called as the β-domain).83 Additionally, a short double stranded antiparallel βsheet and one of the four disulfide bonds [76-94] link the two domains.83 Two disulfide
bonds [6-127] and [30-115] are present within the α-domain, and the remaining disulfide
bond [64-80] is located within the β-domain (Figure 11).42
1.3.5.2 Distributions of conformers during lysozyme folding
Identification of intermediates formed during oxidative folding provides information
about the distributions of disulfide species as folding progress.84 As the number of
cysteine residues increases in a protein, the probability of forming incorrect disulfide
bonds increases. The folding of lysozyme can occur in various steps, each of which
involves oxidation of thiols and thiol/disulfide interchange reactions (Figure 12).85 In the
first oxidation step, species with one disulfide bond and six thiol groups are formed.
There is the possibility of 28 such species, but only four of them have a native disulfide
bond. In the second step, intermediates containing two disulfide bonds and four thiol
groups are formed. Of the 210 possible two disulfide bond containing intermediates, only
six have both disulfide bonds correctly paired. In the third step, intermediates with three
disulfide bonds and two thiol groups are formed. Of the 420 possible structures, only four
have native sets of disulfide bonds. In the fully oxidized state, there are four disulfide
bonds, and of the 105 possible isomeric forms, only one has a native set of disulfide
pairing. On the other hand, when we consider mixed protein-GSH disulfide bonds, the
total number of possible intermediates increases to over 7000. However, during the later
stages of folding, only a small fraction of possible three- and four-disulfide intermediates
accumulate to significant levels. In fact, only 3 three-disulfide bonds containing
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intermediates with native disulfide bonds, and 1 four-disulfide bonded species, the native
protein, have been identified.42
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Figure 12. Schematic diagram of possible disulfide intermediates during the folding of
reduced lysozyme.85
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1.3.5.3 Refolding kinetics of the three-disulfide intermediates
Dobson et al. described the oxidative folding of lysozyme in terms of the disulfide
bonded intermediates that accumulated. An acid quenched method along with reverse
phase HPLC at pH 2.0 was used to separate the intermediates.42 The oxidative protein
folding was carried out at pH 8.5. The elution profile showed that native-like threedisulfide species occurred during the later stages of folding. The most abundant
intermediate was des [76-94], a highly native-like species, which has three native
disulfide bonds but lacks the Cys76-Cys94 disulfide bond. Two minor intermediates were
also observed, des [6-127] and des [64-80], which have native-like structure and threenative disulfide bonds.86 Figure 13 illustrates the disappearance of the fully reduced
protein (R) and the appearance of the three-disulfide intermediates and native protein
(N).42 The results revealed that des [76-94] was the most abundant folding intermediate
and accounted for 40% of the total protein at one stage. Later in folding, des [76-94] and
native protein were the only species populated at significant levels. Although des [76-94]
has a highly native-like structure with essentially native optical properties, its enzymatic
activity is significantly lower (50 ± 5%) than that for native protein.86 Furthermore, they
observed two other three-disulfide intermediates, des [64-80] and des [6-127]. Des [6480] accumulated to lower levels (10-15%) and oxidized more quickly than des [76-94],
whereas des [6-127] was present at even lower levels ( 5%). Since des [76-94] dominated
the later stages of the folding reaction, it was suggested that the conversion of des [76-94]
to native protein is likely the rate limiting step in the folding of the majority of lysozyme
molecules. However, the kinetic profile of des [76-94] revealed that its conversion to
native protein is a very slow process with a time constant of several hours and consistent
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Figure 13. Schematic diagram of the oxidative refolding of lysozyme, showing the
statistical nature and observed kinetics of protein folding. R represents fully reduced
protein, I corresponds to ensemble of early unstructured intermediates, "N" indicates
native-like three-disulfide intermediates, and N represents fully native protein. Figure
from Van den Berg, B. et al, 1999.42
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with the slow phase in the recovery of the enzymatic activity. Thus, it cannot account for
the presence of ~35% native protein after only 60 min of folding and clearly indicates
that ~25-30% of lysozyme molecules do not form the native state via des [76-94]. These
~25-30% of lysozyme molecules could fold via the minor intermediates des [6-127] and
des [64-80], which are converted more rapidly to native protein than des [76-94].
Therefore, des [76-94] appears to act as a kinetic trap.
To support the hypothesis that des [76-94] is a kinetic trap, Dobson et al. carried
out the refolding of purified des [76-94] to native protein at pH 8.5 in refolding buffers
containing 1 or 4 M urea.42 They found that des [76-94] was converted to native protein 3
times faster in 4 M urea than in 1 M urea and the results suggested that des [76-94]
needed to unfold in order to form the final Cys76-Cys94 disulfide bond and generate
native protein. Additionally, in another experiment at pH 7.4, des [76-94] was allowed to
refold in the presence or absence of PDI, buffer containing 1 M urea, and 2 mM/0.4 mM
GSH/GSSG. They found that the refolding rate of des [76-94] to native protein was ~8
times faster in the presence of PDI than in the absence of PDI. Furthermore, the data for
mutant human lysozyme also suggested that the thiol group of Cys76 in des [76-94] is
solvent exposed, whereas that of Cys94 is buried and not accessible to GSSG or a protein
disulfide.87,88 The fact that Cys76 is solvent exposed and Cys94 is buried in des [76-94]
may be the reason for the slow conversion of des [76-94] to fully native state in the
absence of PDI or high concentrations of urea.86
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1.3.6 Bovine pancreatic trypsin inhibitor (BPTI)
1.3.6.1 General information
Cys14-Cys38

Cys30-Cys51

Cys5-Cys55

Figure 14. Rasmol representation of bovine pancreatic trypsin inhibitor.89 (PDB id:
1PIT)
To understand the oxidative folding pathways of disulfide containing proteins
BPTI has been used extensively as a textbook example. BPTI is a monomeric polypeptide
containing 58 amino acid residues, and its native state has two α-helices and two
antiparallel β-sheets. Three disulfide bonds between cysteine residues 14-38, 30-51, and
5-55 stabilize the native state of BPTI (Figure 14).
The protein unfolds when the three disulfide bonds in BPTI are reduced. The
reduced protein can then be refolded by treating it with an oxidizing agent. Various
folding studies of BPTI has been carried out using oxidized glutathione and reduced
glutathione or oxidized and reduced DTT.40,91 During folding of BPTI, the intermediates
formed can be trapped and isolated. The folding pathway of BPTI is described by the
formation of several one-disulfide and two-disulfide intermediates.92 The one- disulfide
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intermediate having a disulfide bond between cysteine 30 and cysteine 51 is denoted as
[30-51] and is a native-like intermediate. Other one-disulfide intermediates seen during
folding are [14-38] and [5-55]. Several two disulfide bond containing intermediates are
also detected during folding [30-51;14-38], [5-55;14-38], and [30-51; 5-55] (Figure 15).90
Some intermediates with disulfide bonds that are not contained in native protein are also
detected during the folding process, and these intermediates are called non-native
intermediates. for e.g. [30-51; 5-14] and [30-51; 5-38].

[30-51]

a)

b)

[30-51; 5-55]

[30-51; 5-55; 14-38]

c)

Figure 15. Folding pathway of BPTI with a) one disulfide intermediate, b) two disulfide
intermediate, and c) native protein. Figure from Bulaj, G. et al., 2001.90
1.3.6.2 Folding pathway of BPTI as proposed by Kim et al.40
The oxidative folding pathway of BPTI is well characterized and has been studied for
four decades by various research groups.40,93-97 The pathway has been described by the
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disulfide bonded intermediates that are formed during the oxidative folding.40,93,98-100 Kim
et al. proposed the folding pathway of BPTI by trapping intermediates with acid (Figure
16).40 Only six well populated disulfide species were seen and none of them contained
non-native disulfide bonds. Reduced BPTI denoted by R is oxidized rapidly to onedisulfide intermediate [30-51] or [5-55]. Both intermediates are thought to have nativelike structure. The thiols of cysteine 14 and cysteine 38 are solvent exposed in these oneProductive pathway
N'
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Figure 16. Schematic representation of folding pathway of BPTI, where N is native
protein and R is reduced protein as represented by Kim et al.40
disulfide intermediates and can form the 14-38 disulfide bond readily to give [30-51; 1438], N', and [5-55; 14-38], N*. Both N' and N* possess native-like structure and serve as
kinetic traps for folding. The N* is very stable and does not undergo further
rearrangement, whereas N' does rearrange slowly to form either [30-51; 5-55], NSH, or
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N*. NSH can then rapidly oxidized to native protein (N). Under suitable oxidizing
conditions, half of the molecules form native BPTI via N', called the productive pathway,
while the other half are kinetically trapped in the form of N*, called the non-productive
pathway. The free thiols in N* are buried and inaccessible to oxidizing agents and thus
N* is kinetically stable.
1.4 Oxidative protein folding
1.4.1 In vitro protein folding
Industrially, the formation of inclusion bodies or aggregates is a serious problem
for the production of disulfide containing proteins by recombinant DNA technology. In
general, the lowest yielding step in the recovery of native protein from the aggregates is
in vitro protein folding.101,41 The yield of in vitro protein folding is affected by many
factors, such as composition of the redox buffer, the presence of folding aids, and the pH
of the folding solution.41,101,102 Furthermore, it has been observed that the refolding yield
decreases with an increase in the concentration of the protein.103,59 It has been shown that
two types of interactions, intermolecular and intramolecular, compete during the
refolding process. The intermolecular interaction is the cause for the decrease in yield as
a function of the protein concentration.59,104 The intramolecular interaction is a
unimolecular process, and the rate of formation of renatured protein is independent of the
protein concentration. Conversely, the intermolecular interaction is a second or higher
order process, and as a result, the rate of aggregation increases with protein
concentration. One of the ways to improve the refolding yield is to suppress the
formation of aggregates. A simple method is to carry out protein refolding at very dilute

31

concentrations (e.g. <0.1 mg/mL). However, large volumes of refolding solution are
needed to carry out the refolding process, thereby increasing the production cost and
time.
1.4.1.1 Folding aids
To date, a number of methods have been proposed to increase the refolding yield
at moderate to high protein concentrations. One efficient strategy is the addition of
folding aids. The most commonly used folding aids are guanidine hydrochloride, urea,
arginine, and glycerol.18,27,105-109 Other additives include detergent and surfactants,
polyethylene glycol, molecular chaperones, artificial chaperones, and several simple
compounds, such as acetone, acetamide, sarcosine, and thiourea.106,110-115 Folding aids are
proposed to increase the refolding yield by interfering with the intermolecular
hydrophobic interactions. However, folding aids generally decrease the rate of folding.105107

Moreover, folding aids must be optimized for each protein, as folding aids have

different effect on different proteins.
1.4.1.2 Redox buffer
Another technique to improve the yield of renatured protein in in vitro protein
folding is the use of a redox buffer. A redox buffer is composed of a small molecule
disulfide and/or a small molecule thiol.5,32,116 The most commonly used redox buffer
contains oxidized glutathione (GSSG) and reduced glutathione (GSH). Numerous studies
have been carried out using aliphatic thiol based redox buffers to fold inclusion bodies.
Extensively studied aliphatic thiol based redox buffers include GSH (pKa= 8.7),
dithiothreitol (DTT) (pKa= 9.2), and β-mercaptoethanol (pKa= 9.6). However, aliphatic
thiol based redox buffers have low folding rates below pH 7.5, as very little (less than
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3%) of the aliphatic thiol is in the reactive thiolate form (pKa approximately 9). Recently,
improved redox buffers have been used, such as aliphatic dithiols, synthetic peptides, and
aromatic monothiols.32,34-38,116 Aliphatic dithiols, e.g. [(±)-trans-1,2-bis(2-mercaptoactamido) cyclohexane (BMC)] with a thiol pKa of 8.3, and synthetic peptides can
increase the overall yield. Raines et al. illustrated that the BMC increased the yield of
native RNase A by two fold relative to its monothiol analog, N-methylmercaptoacetamide
(NMA). The increase in yield was because of the presence of a second thiol group in
BMC versus a single thiol group in NMA. Furthermore, Raines et al. showed that
addition of BMC to S. cerevisiae growth medium increased the heterologous production
of Schizosaccharomyces pombe acid phosphatase. However, BMC and synthetic peptides
do not change the folding rate constant. Moreover, dithiols with a second thiol group
have an advantage over monothiols (Figure 17). When dithiols or monothiols react with a
protein disulfide bond, they produce a mixed disulfide bond. With the dithiols, but not
monothiols, the second thiol group acts as a clock and provides a set amount of time for
the protein to rearrange. If the protein does not rearrange, then the second thiol of the
dithiol makes an intramolecular attack and disrupts the mixed disulfide bond. In the case
of monothiols, there is no second thiol to act as a clock and the mixed disulfide can
become kinetically trapped, and thus the overall yield of native protein decreases.
Furthermore, in previous studies by our group, it has been shown that aromatic
monothiols (pKa 5.5-6.6) increased the folding rate and the overall yield of native protein
compared to standard aliphatic thiols (pKa 8.5-10). With aromatic monothiols, the folding
rate of ribonuclease A was 10-23 times faster than with glutathione at pH 6.0, 7-12 times
faster at pH 7.0, and 5-8 times faster at pH 7.70.4,35,117 Additionally, it was also
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Figure 17. a) Thiol/disulfide interchange reaction with dithiols, such as PDI, showing
escape mechanism.32 b) Thiol/disulfide interchange reaction with monothiol showing
kinetic trap, as a mixed disulfide between monothiol and protein substrate.
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demonstrated that at a high protein concentration (1 mg/mL of lysozyme), aromatic
monothiols, 4-mercaptobenzylphosphonic acid (2) and quaternary ammonium salt (3)
(pKa 5.5-6), increased the folding rate and yield of lysozyme by 11 times and 20-40%,
respectively, at pH 7, and by 7 times and 25%, respectively, at pH 8 in comparison with
glutathione (pKa 8.7).38 By combining the advantageous properties of aromatic
monothiols and aliphatic dithiols, I proposed to design aromatic dithiols which will
increase the protein folding rate and overall yield of native protein.
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Chapter 2

Specific Aims
Most pharmaceutically relevant proteins and many extracellular proteins contain
disulfide bonds.4 Disulfide bonds between the correct cysteine residues are essential for
the stability and activity of almost all disulfide-containing proteins. Because of progress
in the field of biotechnology, proteins can now be overexpressed in bacterial cells.
During overexpression, bacteria produce large quantities of high value protein in a rapid
and inexpensive way. However, overexpressed proteins, especially disulfide-containing
ones, are frequently deposited as insoluble aggregates inside the bacterium, called
inclusion bodies.101 The protein within the aggregates is inactive and non-native. To
obtain native protein, it is necessary to isolate and resolubilize the aggregates, and then
fold the resulting protein in vitro.16 The formation of the correct disulfide bonds during in
vitro protein folding is the slowest. In vitro protein folding is aided by the addition of a
redox buffer, which is composed of a small molecule disulfide and/or a small molecule
thiol.5 The most commonly used redox buffer contains reduced glutathione (GSH) and
oxidized glutathione (GSSG). Many in vitro protein folding studies have been carried out
using aliphatic thiol based redox buffers. Examples of aliphatic thiol based redox buffers
include dithiothreitol (pKa 9.2), glutathione (pKa 8.7), β-mercaptoethanol (pKa 9.6), and
cysteine (pKa 8.3). Recently, more improved redox buffers have been employed, such as
aliphatic dithiols, synthetic peptides, and some aromatic monothiols. Aliphatic dithiols,
e.g., (±)-trans-1,2-bis(2-mercapto-actamido)cyclohexane (BMC) and synthetic peptides
have been shown to improve the overall yield of native protein as compared to standard
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aliphatic thiols (pKa 8.5 - 10) such as glutathione.32 Dithiols were designed on the basis
of the in vivo protein folding catalyst, protein disulfide isomerase (PDI), which has two
thiols in each active site. Furthermore, aromatic monothiols (pKa 5.5 - 6.6) have been
demonstrated to increase the folding rate of lysozyme and RNase A in comparison with
traditionally used aliphatic thiols such as glutathione.4 By combining the beneficial
properties of aliphatic dithiols and aromatic monothiols, I propose to design aromatic
dithiols that will increase the in vitro protein folding rates and overall yields of the
disulfide containing proteins.
1) To synthesize the following aromatic monothiols and their disulfides on a multigram
scale for the folding of lysozyme and bovine pancreatic trypsin inhibitor.
HO
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2) To synthesize two series of aromatic ethylene glycol dithiols and determine their
ability to enhance the in vitro folding rates and yields of lysozyme.
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3) To synthesize aromatic quaternary ammonium salt dithiols and use them for the
folding of lysozyme at high protein concentration (1 mg/mL).
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m = 1,4
16, 17
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Chapter 3

Materials and general methods
Hen egg white lysozyme was purchased from Roche Applied Sciences and used
without further purification. Bis tris propane, Tris, sodium ethylenediaminetetraacetate
(EDTA), dithiothreitol (DTT), Micrococcus lsyodeikticus, guanidine hydrochloride (Gdn
HCl), and the reduced and oxidized forms of glutathione (GSH and GSSG, respectively)
were purchased from Sigma. Sephadex G-25 was purchased from GE Healthcare. The
reagents used to synthesize ortho-substituted aromatic mono-, di-, tri-, and tetraethylene
glycol dithiols (9, 10, 11, and 12) and para-substituted aromatic di-, tri-, and
tetraethylene glycol dithiols (13, 14, and 15) were purchased from Aldrich. The pmercaptobenzoic acid (1) and its disulfide (5) were synthesized as described
previously.43,118 1H NMR spectra were referenced to TMS at 0.00 ppm. 13C NMR spectra
were referenced to 77.00 ppm (CDCl3) or 49.00 ppm (CD3OD). Elemental analyses were
performed by Galbraith Laboratories, Inc., Knoxville, TN. High resolution mass
spectroscopy (HRMS) was conducted by Florida State University, Tallahassee, FL.
3.1 Synthesis of aromatic monothiols and their corresponding disulfides (1-8)
3.1.1 Synthesis of 4-mercaptobenzoic acid (1)43,119
3.1.1.1 Synthesis of methyl 4-(dimethylcarbamothioyloxy)benzoate (20)
CO2CH3

S
Cl N
19

CO2CH3

DABCO, DMF
OH

95%

O

N
S

18

20
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Methyl 4-hydroxybenzoate (18) (38.75 g, 0.254 mol) and 1,4-diazabicylco [2.2.2]
octane (DABCO) (80.0 g, 0.713 mol) were dissolved in 300 mL of DMF. After all of the
solid had been dissolved, N,N-dimethylthiocarbamoylchloride (19) (42.0 g, 0.339 mol)
was added to the solution. The solution was stirred for 1.5 h at 65 oC. The reaction
mixture was then poured onto crushed ice and acidified to pH 3 with 6.0 N HCl. The
white precipitate that formed was filtered and recrystallized from ethanol to provide
57.43 g of methyl 4-(dimethylcarbamothioyloxy)benzoate (20), 95% yield.
1

H NMR (CDCl3, 400 MHz) δ 8.08 (d, J = 8.7 Hz, 2H), 7.14 (d, J = 8.7 Hz, 2H), 3.91 (s,

3H), 3.45 (s, 3H), 3.35 (s, 3H).
3.1.1.2 Synthesis of methyl 4-(dimethylcarbamoylthio)benzoate (21)
CO2CH3

CO2CH3


O

N

210-240 oC
34%

S

N

S

O

20

21

Methyl 4-(dimethylcarbamothioyloxy)benzoate (20) (23.80 g 0.099 mol) was
added to a 500- mL round bottom flask and then heated to 210-240 oC. After 2.5 h, the
flask was cooled to room temperature. The residue was recrystallized from cyclohexane
and then twice from ethanol to give 8.0 g of methyl 4-(dimethylcarbamoylthio)benzoate
(21), 34% yield.
1

H NMR (CDCl3, 400 MHz) δ 8.03 (d, J = 8.6 Hz, 2H), 7.57 (d, J = 8.6 Hz, 2H), 3.92 (s,

3H), 3.10 (brs, 3H), 3.04 (brs, 3H).
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3.1.1.3 Synthesis of 4-mercaptobenzoic acid (1)
CO2CH3

COOH
NaOH, MeOH
H2O, 

S

N

74%

SH

O
21

1

Argon was bubbled through a solution of NaOH (3.61 g, 0.090 mol) in 40 mL of
MeOH and 1 mL of H2O. After 15 min, methyl 4-(dimethylcarbamoylthio)benzoate (21)
(7.75 g, 0.032 mol) was added to it, and the mixture was refluxed under Ar for 3 h. The
reaction mixture was concentrated in vacuo. The residue was then poured onto crushed
ice and acidified to pH 2 with 2.0 N HCl. The aqueous layer was extracted with ethyl
acetate (3 x 100 mL), and the combined organic layers were then washed with brine (2 x
100 mL), dried (MgSO4), and concentrated in vacuo. The residue was then recrystallized
from benzene to provide 4.0 g of 4-mercaptobenzoic acid (1) as light yellow crystals,
74% yield.
1

H NMR (CD3OD, 400 MHz) δ 7.87 (d, J = 8.5 Hz, 2H), 7.36 (d, J = 8.6 Hz, 2H). 13C

NMR (MeOD, 100 MHz) δ 169.5, 141.0, 131.3, 128.9, 128.4.
3.1.1.4 Synthesis of 4,4'-disulfanediyldibenzoic acid [disulfide of 4-mercaptobenzoic
acid (5)]118
COOH

COOH
I2
EtOH

SH

86%

1

S
2
5
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The 4-mercaptobenzoic acid (1) (1.25 g, 8.11 mmol) was dissolved in ethanol,
and a saturated solution of I2 in 95% ethanol was slowly added to it. The progress of the
reaction was monitored by the disappearance of the brown color of iodine. The saturated
solution of iodine was continuously added until a light yellow color persisted. The off
white precipitate was filtered and washed with ethanol. The precipitate was dried with
benzene under reduced pressure to remove any adsorbed iodine and ethanol to give 1.07
g of product (5), 86% yield.
1

H NMR (DMSO, 400 MHz) δ 7.93 (d, J = 8.5 Hz, 4H), δ 7.63 (d, J = 8.2 Hz, 4H); 13C

NMR (DMSO, 100 MHz) δ 166.6, 140.7, 130.2, 129.7, 126.1.
3.1.2 Synthesis of 4-mercaptobenzylphosphonic acid (2)
3.1.2.1 Synthesis of S-p-tolyl benzothioate (24)120,121
CH3

CH3
NEt3/toulene

SH

22

78%
O

S

Cl

O

Ph
24

23

To toluene (2 L), p-toluenethiol (22) (51.20 g, 0.412 mol) and benzoyl chloride
(23) (58.65 g, 0.420 mol) were added. The solution was cooled to 0 oC, and triethylamine
(40.77 g, 0.402 mol) was added slowly with stirring for 1 h. The reaction mixture was
stirred for an additional 1 h, filtered, and the solid washed with toluene. The fitrate was
then washed with water, dried (MgSO4), filtered, and concentrated in vacuo. The crude
was recrystallized from ethanol to provide 73.58 g of S-p-tolyl benzothioate (24), 78%
yield. 1H NMR (CDCl3, 400 MHz) δ 8.01 (d, J = 7.4 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H),
7.48 (t, J = 7.9 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 7.26 (d, J = 8.3 Hz, 2H), 2.40 (s, 3H).
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3.1.2.2 Synthesis of S-4-(bromomethyl)phenyl benzothioate (25)120
Br
CH3
NBS, h
69%
S

S

O

Ph

Ph

24

25

O

To deoxygenated benzene (170 mL), S-p-tolyl benzothioate (24) (27.31 g, 0.120
mol) and N-bromosuccinimide (21.39 g, 0.120 mol) were added. The reaction mixture
was then irradiated with a 250W GE heat lamp, providing sufficient energy to initiate
reflux. After 30 min at reflux, the solution was cooled to 0 oC, filtered, and concentrated
in vacuo. The residue was then partitioned between 800 mL of CH2Cl2 and 400 mL of
water. The aqueous layer was washed with 200 mL of CH2Cl2. The organic layers were
combined, dried (MgSO4), filtered, and concentrated in vacuo. The solid was then
recrystallized from hexanes to provide 25.09 g of product, approximate 69% yield, as a
24:1

mixture

of

S-4-(bromomethyl)phenyl

benzothioate

(25)

and

S-4-

(dibromomethyl)phenyl benzothioate.
1

H NMR (CDCl3, 400 MHz) δ 8.01 (d, J = 8.8 Hz, 2H), 7.62 (t, J = 7.4 Hz, 1H), 7.52 -

7.47 (m, 6H), 4.52 (s, 2H).
3.1.2.3 Synthesis of S-4-((diethoxyphosphoryl)methyl)phenyl benzothioate (26)122
Triethylphosphite (34.49 g, 0.207 mol) was added to the 24:1 mixture of S-(4bromomethyl)phenyl benzenecarbothioic acid (25) and S-(4-dibromomethyl)phenyl
benzenecarbothioic acid (24.48 g, 0.079 mol). The reaction mixture was then stirred at
105 oC under a flow of Ar. After 90 min of stirring, the reaction mixture was cooled to -5
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o

C in the freezer to give crystals. The crystals were washed with hexanes and then

recrystallized

from

hexanes:

CH2Cl2

(95:5)

to

provide

19.96

g

of

S-4-

((diethoxyphosphoryl)methyl)phenyl benzothioate (26), 69% yield.
EtO
Br

EtO

O

P

P(OEt)3
105 oC

S

1

69%

O

S

Ph

Ph

25

26

O

H NMR (CDCl3, 400 MHz) δ 8.01 (d, J = 7.3 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H), 7.50 -

7.45 (m, 4H), 7.39 (dd, J = 8.3, 2.3 Hz, 2H), 4.04 (quintet, J = 7.3 Hz, 4H), 3.20 (d, J =
21.8 Hz, 2H), 1.26 (t, J = 7.1 Hz, 6H).
3.1.2.4 Synthesis of S-4-((diethoxyphosphoryl)methyl)phenyl ethanethioate (27)
EtO
EtO

P

EtO

O

EtO

P

O

1) NaOEt/EtOH
2) Ac2O
S

O

94%

S

O

Ph
27

26

Sodium hydride (7.47 g of 60 wt%, 0.186 mol) was added to ethanol (1150 mL)
and the solution was deoxygenated by bubbling Ar through it for 45 min. S-4((diethoxyphosphoryl)methyl)phenyl benzothioate (26) (19.96 g, 0.054 mol) was added
to the solution, and after 25 min the reaction was quenched by adding acetic anhydride
(56.68 g, 0.55 mol). Absence of thiol groups were detected by a negative Ellman’s test.
The solution was reduced under pressure and the slurry was partitioned between 1400 mL
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of CH2Cl2 and 700 mL of sat. aq. sodium bicarbonate. The water layer was washed with
an additional 700 mL of CH2Cl2. The combined organic layers were dried (MgSO4),
filtered, and concentrated in vacuo. The crude material was subjected to flash
chromatography (1:1 hexanes/ethyl acetate to pure ethyl acetate) to provide 15.29 g of S4-((diethoxyphosphoryl)methyl)phenyl ethanethioate (27) as an oil, 94% yield. 1H NMR
(CDCl3, 400 MHz) δ 7.35 (s, 4H), 4.02 (quintet, J = 7.2 Hz, 4H), 3.16 (d, J = 21.8 Hz,
2H), 2.40 (s, 3H), 1.24 (t, J = 7.1 Hz, 6H).
3.1.2.5 Synthesis of 4-mercaptobenzylphosphonic acid (2)122
EtO
EtO

P

HO

O

HO

P

O

HCl, 
78%
S

SH

O

27

2

The S-4-((diethoxyphosphoryl)methyl)phenyl ethanethioate (27) (3.05 g, 0.0100
mol) was added to conc HCl (500 mL) and heated at 130 oC for 5 h. The reaction mixture
was reduced to approximately 100 mL by concentrating in vacuo, filtered, and cooled to
0 oC. The solution was filtered, and the solid was washed with water. The solid was then
lyophilized to provide 1.58 g of 4-mercaptobenzylphosphonic acid (2), 78% yield.
1

H NMR (CD3OD, 400 MHz) δ 7.22 - 7.16 (m, 4H), 3.05 (d, J = 21.6 Hz, 2H); 13C NMR

(CD3OD, 100 MHz) δ 131.6, (d, J = 6 Hz), 131.5, 131.1 (d, J = 4 Hz), 130.1 (d, J = 3
Hz), 35.2 (d, J = 135 Hz).
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3.1.2.6 Synthesis of 4,4'-disulfanediylbis(4,1-phenylene)bis(methylene)diphosphonic
acid [disulfide of 4-mercaptobenzylphosphonic acid (6)]38

HO
HO

P

HO

O

P

HO

O

O2
83%
SH

S

2

6

2

The 4-mercaptobenzylphosphonic acid (2) (0.506 g, 2.50 mmol) was dissolved in
30 mL of water, and the resulting mixture was stirred vigorously under air. After 1 week,
the mixture was filtered by suction filtration to provide 0.417 g of 4,4'disulfanediylbis(4,1-phenylene)bis(methylene)diphosphonic acid (6) as a white solid,
83% yield.
1

H NMR (DMSO, 400 MHz) δ 7.44 (d, J = 7.8 Hz, 4H), 7.25 (d, J = 6.8 Hz, 4H), 2.94

(d, J = 21.5 Hz, 4H); 13C NMR (DMSO, 100 MHz) δ 134.2 (d, J = 9 Hz), 133.2 (d, J = 3
Hz), 130.8 (d, J = 6 Hz), 127.5 (d, J = 2 Hz), 34.9 (d, J = 131 Hz).
3.1.3 Synthesis of quaternary ammonium thiol salt (Mono QAS) (3)
3.1.3.1

Synthesis

of

1-(4-(benzoylthio)phenyl)-N,N,N-trimethylmethanaminium

bromide [quaternary ammonium salt (28)]120
Br

Br

N
NMe3

S

81%
O

S

Ph

Ph

25

28

46

O

Trimethylamine (38.33 mL of a 33% solution in ethanol, 0.471 mol) was rapidly
added to benzyl bromide (25) (25.0 g, 0.081 mol) at 0 oC and stirred. After 10 min, the
mixture was concentrated in vacuo, and then the residue was recrystallized from
EtOAc/EtOH (95:5) to give 18.85 g of the quaternary ammonium salt (28), 81% yield.
1

H NMR (CDCl3, 400 MHz) δ 7.98 (d, J = 7.2 Hz, 2H), 7.81 (d, J = 8.2 Hz, 2H), 7.63-

7.59 (m, 3H), 7.49 (t, J = 8.0 Hz, 2H), 5.21 (s, 2H), 3.42 (s, 9H).
3.1.3.2

Synthesis

of

1-(4-(mercaptophenyl)-N,N,N-trimethylmethanaminium

bromide [Mono QAS (3)]120
Br

Br

N

N
HBr
quantitative

S

SH

O

Ph
3

28

The quaternary ammonium salt (28) (0.93 g, 2.54 mmol) was lyophilized from
water and then dissolved in 3 mL of HBr (48 wt.% in water) and 15 mL of water. The
solution was refluxed for 5 h, cooled to 0 oC, filtered, extracted with 2 x 30 mL EtOAc,
and partially concentrated. The solution was then lyophilized several times by dissolving
the residue in water to give Mono QAS (3) in quantitative yield.
1

H NMR (CD3OD, 400 MHz) δ 7.44 (s, 4H), 4.50 (s, 2H), 3.10 (s, 9H).

3.1.3.3

Synthesis

of

1,1'-(4,4'-disulfanediylbis(4,1-phenylene)bis(N,N,N-

trimethylmethanaminium) bromide [disulfide of Mono QAS (7)]38
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Br
N

Br

N
O2
H2O
quantitative

SH

S
2

3

7

Disulfide of Mono QAS (7) was prepared from Mono QAS (3). Mono QAS (3)
was dissolved in 50 mL of water and the resulting mixture was stirred vigorously under
air. After 6 months, the solution was lyophilized to provide disulfide of Mono QAS (7).
1

H NMR (CD3OD, 400 MHz) δ 7.68 (d, J = 8.5 Hz, 4H), 7.61 (d, J = 8.5 Hz, 4H), 4.60

(s, 4H), 3.13 (s, 18H).
3.1.4. Synthesis of 4-mercaptobenzene sulfonic acid (4)
3.1.4.1 Synthesis of 4-mercaptobenzene sulfonic acid (4)123

OH
O S O

1) NaOH

O H3N
O S O

2) NaNO2, HCl

H+
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4)

MeOH, H2O
S

12% overall yield

S
2

NH3 Cl

O S O
PPh3

3) S8, Na2S
NH2

OH

OH
O S O

SH

2
31

30

4

A solution of sodium hydroxide (20.05 g, 0.50 mol) in 500 mL of water was
prepared, and then 4-aminobenzenesulfonic acid (29) (86.48 g, 0.50 mol) was dissolved
in it. To the reaction mixture, 100 mL of conc HCl was added followed by gradual
addition of a solution of sodium nitrite (34.54 g, 0.50 mol) in 100 mL of water at 1-3 oC.
The resulting suspension was then slowly added into a solution of sodium disulfide at 1-3
o

C. The solution of sodium disulfide was prepared by co-melting sulfur (16.01 g, 0.50
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mol) and sodium sulfide nonahydrate (120.1 g, 0.50 mol) at 65 oC, in 500 mL of water.
The reaction mixture was warmed until the evolution of gas ceased and then returned to
room temperature. The insoluble material was filtered off. To the filtrate, a freshly
prepared solution of aniline (93.4 g, 1.00 mol) and conc HCl (84 mL) in 200 mL of water
were added. The mixture was then cooled overnight. The precipitate was filtered,
recrystallized from water, and then washed with ethanol and n-hexane to give 23.87 g
mixture (30:70) of a mono- and dianilinium 4,4'-dithiobis(benzenesulfonate) (30) as
colorless crystals.
1

H NMR (DMSO, 400 MHz) δ 7.59 (d, J = 8.4 Hz, 4H), 7.48 - 7.42 (m, 6.8H), 7.31 (t, J

= 7.4 Hz, 1.4H), 7.25 (d, J = 8.6 Hz, 2.8H).
The mixture of a mono- and dianilinium 4,4'-dithiobis(benzenesulfonate) (30)
(8.70 g) was then subjected to ion-exchange column chromatography (63 mL of Dowex
50X2-200, H-form) using methanol: water (2:1) as the eluent. The acidic fractions were
collected and reduced under pressure to give the residue (31).
1

H NMR (CD3OD, 400 MHz) δ 7.77 (d, J = 8.5 Hz, 4H), 7.58 (d, J = 8.5 Hz, 4H).
The residue (31) was dissolved in 145 mL of methanol, and then

triphenylphosphine (8.84 g, 0.033 mol) and about 1 mL of water were added. The
reaction mixture was stirred overnight at room temperature and then evaporated in vacuo.
The residue was dissolved in 90 mL of CH2Cl2, and the organic layer was washed with
water. The organic layer was dried (MgSO4), filtered, reduced under pressure, and then
the residue was dissolved in dioxane followed by filtration of insoluble materials. The
filtrate was reduced under pressure, and the resulting oil was recrystallized from benzene
to give 4-mercaptobenzensulfonic acid (4) (4.28 g, 12% overall yield) as yellow crystals.
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1

H NMR (CD3OD, 400 MHz) δ 7.66 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.5 Hz, 2H).

3.1.4.2 Sodium salt of sulfonic acid disulfide (8)

OH
O S O

Na
O
O S O

O H3N
O S O

1) NaOH

Na+

2) NaNO2, HCl
3) S8, Na2S
NH2

4)

overall
yield 13%

S

S

2
NH3 Cl

29

30

2

8

Sodium ions were exchanged with H+ ions by treating the Dowex 50wx2 H+ form
with 0.1 M NaOH and 0.5 M NaCl in 500 mL of water. Water was run through the resin
to make it neutral followed by methanol:water (2:1) to equilibrate the resin with
methanol:water. The dianilinium salt (30) (5.16 g, 9.15 mmol) was then subjected to ion
exchange resin (Na+ form) with methanol:water (2:1) as the eluent. The fractions those
were UV active were collected and evaporated in vacuo to give the sodium salt of
sulfonic acid disulfide (8) (3.02 g, 13% yield).
1

H NMR (DMSO, 400 MHz) δ 7.59 (d, J = 8.4 Hz, 4H), 7.46 (d, J = 8.4 Hz, 4H).

3.2 Synthesis of ortho-and para-substituted aromatic ethylene glycol dithiols (9-15)
3.2.1 Synthesis of di-, tri-, tetra-, and hexaethylene glycol thiols (35, 36, 43, and 44)
3.2.1.1

Synthesis

of

2-(2-mercaptoethoxy)ethanol

and

2-[2-(2-

mercaptoethoxy)ethoxy]ethanol [di- and triethylene glycol thiols (35 and 36)]124
S
HO
H2N

1) reflux

O
m

NH2

Cl
2) NaOH
3) HCl

m = 1, 2
32

HO

59%, 67%

33, 34

50

O

m SH

m = 1, 2
35, 36

General procedure
Thiourea (32) (3.67 g, 0.048 mol) and 2-[2-(2-chloroethoxy)ethoxy]ethanol (34)
(5.27 g, 0.031 mol) were dissolved in 100 mL of water, and the solution was bubbled
with argon for 30 min and then heated to reflux under argon. After 18 h, the reaction
mixture was cooled to room temperature, and then a solution of NaOH (10.53 g, 0.263
mol) in 50 mL of deoxygenated H2O was added to it. The reaction mixture was refluxed
for another 3 h and then poured onto ice and adjusted to pH 4 with conc HCl under argon.
The reaction mixture was washed with CHCl3 (3 x 100 mL). The organic layers were
combined and then extracted with brine (2 x 100 mL), dried over MgSO4, filtered, and
concentrated under reduced pressure to leave 3.50 g of the triethylene glycol thiol (36) as
a colorless oil, 67% yield.
2-(2-Mercaptoethoxy)ethanol [diethylene glycol thiol (35)]: 59% yield, 1H NMR
(CDCl3, 400 MHz) δ 3.73 (q, J = 4.8 Hz, 2H), 3.61 (t, J = 6.3 Hz, 2H), 3.57 (t, J = 4.7
Hz, 2H), 2.70 (dt, J = 8.2, 6.3 Hz, 2H), 2.29 (t, J = 5.8 Hz, 1H), 1.56 (t, J = 8.2 Hz, 1H).
2-[2-(2-Mercaptoethoxy)ethoxy]ethanol [triethylene glycol thiol (36)]: 67% yield, 1H
NMR (CDCl3, 400 MHz) δ 3.73 (t, J = 4.5 Hz, 2H), 3.69 - 3.60 (m, 8H), 2.70 (dt, J = 8.2,
6.4 Hz, 2H), 2.42 (brs, 1H), 1.58 (t, J = 8.2 Hz, 1H).
3.2.1.2

Synthesis

methylbenzenesulfonate

of
and

2-[2-(2-(2-hydroxyethoxy)ethoxy)ethoxy]ethyl-417-hydroxy-3,6,9,12,15-pentaoxaheptadecyl-4-

methylbenzenesulfonate [tetra- and hexaethylene glycol monotosylate (41 and 42)]125
General procedure
para-Toluenesulfonyl chloride (14.25 g, 0.075 mol) was suspended in
tetraethylene glycol (39) (29.1 g, 0.15 mol) at 0 oC, and triethylamine (18.75 mL, 0.133
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mol) was then added drop wise to the suspension while maintaining the reaction mixture
at 0 oC. The suspension was stirred at 0 oC for 1 h and then for 16 h at room temperature.

O

OH
m

p-TsCl, NEt3
16 h

OH
45%, 50%

O

OH
m

O
Ts

m = 3, 5

m = 3, 5

39, 40

41, 42

The resulting suspension was dissolved in 500 mL of CH2Cl2 and washed with 1 M HCl
(2 x 125 mL) followed by 250 mL of distilled water. The organic layer was dried with
MgSO4, filtered, and reduced under pressure to give 17.82 g of the mono- and ditosylate
of tetraethylene glycol. The residue was then purified by flash chromatography using
hexane/ethyl acetate (3:1, v/v)  (0:1, v/v) to give 11.23 g of tetraethylene glycol
monotosylate (41), 45% yield .
2-[2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy]ethyl-4-methylbenzenesulfonate
[tetraethylene glycol monotosylate (41)]: 45% yield, 1H NMR (CDCl3, 400 MHz) δ
7.80 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.16 (t, J = 4.8 Hz, 2H), 3.70 - 3.59 (m,
14H) 2.54 (brs, 1H), 2.45 (s, 3H).
2,2'-(2,2'-Oxybis(ethane-2,1-diyl)bis(oxy))bis(ethane-2,1-diyl)bis(4methylbenzenesulfonate [tetraethylene glycol ditosylate]: 1H NMR (CDCl3, 400 MHz)
δ 7.77 (d, J = 8.3 Hz, 4H), 7.32 (d, J = 8.3 Hz, 4H), 4.13 (t, J = 4.8 Hz, 4H), 3.66 (t, J =
4.8 Hz, 4H), 3.54 (m, 8H) 2.43 (s, 6H).
17-Hydroxy-3,6,9,12,15-pentaoxaheptadecyl-4-methylbenzenesulfonate
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[hexaethylene glycol monotosylate (42)]: 50% yield, 1H NMR (CDCl3, 400 MHz) δ
7.79 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.2 Hz, 2H), 4.15 (t, J = 4.8 Hz, 2H), 3.71 - 3.58 (m,
22H), 2.90 (brs, 1H), 2.45 (s, 3H);

13

C NMR (CDCl3, 100 MHz) δ 144.78, 133.00,

129.81, 127.93, 72.49, 70.67, 70.55, 70.52, 70.50, 70.49, 70.46, 70.28, 69.27, 68.62,
61.64, 21.60.
3.2.1.3 Synthesis of 2-[2-(2-(2-mercaptoethoxy)ethoxy)ethoxy]ethanol and 17mercapto-3,6,9,12,15-pentaoxaheptadecan-1-ol [tetra- and hexaethylene glycol thiol
(43 and 44)]125
O
O
Ts
m = 3, 5

OH
m

1. Thiourea
EtOH, 24 h
2. NaOH/EtOH
H2O, 2.5 h
89%, 58%

O

OH
m

SH
m = 3, 5
43, 44

41, 42

General procedure
Tetraethylene glycol monotosylate (41) (5.32 g, 0.015 mole) and thiourea (1.16 g,
0.015 mole) were dissolved in 36 mL of absolute ethanol and heated to reflux under an
argon atmosphere. After 24 h, a solution of NaOH (1.56 g, 0.039 mole) in 22 mL of
ethanol/water (9:1 v/v) was added and then the solution was reflux under an argon
atmosphere for another 2.5 h. Subsequently, the reaction mixture was cooled down to
room temperature and then acidified to pH 2 with conc HCl. The acidic solution was
reduced under pressure, and then the residue was dissolved in 64 mL of ethyl
acetate/ethanol mixture (5:1, v/v) and heated for 5 min at 50 oC before filtering. The
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crude product was purified by flash chromatography using ethyl acetate/ethanol (10:1,
v/v) giving 2.84 g of a tetraethylene glycol thiol (43) as yellow oil, 89% yield.
2-[2-(2-(2-Mercaptoethoxy)ethoxy)ethoxy]ethanol [tetraethylene glycol thiol (43)]:
89% yield, 1H NMR (CDCl3, 400 MHz) δ 3.70 - 3.58 (m, 14H), 2.68 (dt, J = 8.1, 6.4 Hz,
2H), 1.61 (t, J = 8.2 Hz, 1H).
17-Mercapto-3,6,9,12,15-pentaoxaheptadecan-1-ol [hexaethylene glycol thiol (44)]:
58% yield, 1H NMR (CDCl3, 400 MHz) δ 3.67 - 3.54 (m, 22H), 2.65 (t, J = 4.8 Hz, 2H);
13

C NMR (CDCl3, 100 MHz) δ 74.13, 73.72, 71.63, 71.62, 71.60, 71.58, 71.57, 71.45,

71.21, 62.28, 24.76.
3.2.2 Synthesis of di-, tri-, tetra-, and hexaethylene glycol disulfides (37, 38, 45, and
46)
O

HO

m

SH

H2O, Et3N

O

HO

m

S

45%, 84%,91%, 95%

2

m = 1, 2, 3, 5

m = 1, 2, 3, 5

37, 38, 45, 46

35, 36, 43, 44

General procedure
Triethylamine (0.5 mL, 3.58 mmol) was added to a solution of 2-[2-(2mercaptoethoxy) ethoxy]ethanol (triethylene glycol thiol) (36) (3.5 g, 21.08 mmol) in 25
mL of distilled water. The solution was stirred vigorously for 1 week under air. The
reaction mixture was brought to pH 4 with conc HCl, and the aqueous layer was then
extracted with CHCl3 (3 x 25 mL). The organic layers were combined and washed with
brine (2 x 25 mL), dried over MgSO4, filtered, and reduced under pressure to give 2.93 g
of triethylene glycol disulfide (38) as a yellow oil, 84% yield.
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2,2'-(2,2'-Disulfanediylbis(ethane-2,1-diyl)bis)oxy))diethanol

[diethylene

glycol

disulfide (37)]: 45% yield, 1H NMR (CDCl3, 400 MHz) δ 3.78 - 3.73 (m, 8H), 3.60 (t, J
= 4.4 Hz, 4H), 2.94 (t, J = 6.3 Hz, 4H), 2.61 (t, J = 6.2 Hz, 2H).
3,6,13,16-Tetraoxa-9,10-dithiaoctadecane-1,18-diol

[triethylene

glycol

disulfide

(38)]: 84% yield, 1H NMR (CDCl3, 400 MHz) δ 3.75 - 3.70 (m, 8H), 3.66 - 3.63 (m, 8H),
3.59 (t, J = 4.5 Hz, 4H), 3.04 (t, J = 5.5 Hz, 2H) 2.90 (t, J = 6.6 Hz, 4H); 13C NMR
(CDCl3, 100 MHz) δ 72.6, 70.4, 70.3, 69.6, 61.7, 38.4.
3,6,9,16,19,22-Hexaoxa-12,13-dithiatetracosane-1,24-diol

[tetraethylene

glycol

disulfide (45)]: 91% yield, 1H NMR (CDCl3, 400 MHz) δ 3.72 (t, J = 6.7 Hz, 4H), 3.68 3.63 (m, 20H), 3.60 (t, J = 4.5 Hz, 4H), 2.89 (t, J = 6.7 Hz, 4H), 2.74 (t, J = 5.7 Hz, 2H);
13

C NMR (CDCl3, 100 MHz) δ 72.4, 70.4, 70.3, 70.1, 69.4, 61.4, 38.2.

3,6,9,12,15,22,25,28,31,34-Decaoxa-18,19-dithiahexatriacontane-1,36-diol
[hexaethylene glycol disulfide (46)]: 95% yield, 1H NMR (CDCl3, 400 MHz) δ 3.68 3.51 (m, 44H), 2.90 (brs, 2H), 2.82 (t, J = 6.7 Hz, 4H); 13C NMR (CDCl3, 100 MHz) δ
72.7, 70.53, 70.52, 70.45, 70.44, 70.42, 70.3, 70.2, 69.5, 61.5, 38.4.
3.2.3 Synthesis of ortho- and para-substituted aromatic ethylene glycol dithiols
polymer126
General procedure
In 4 mL of THF was dissolved 4,4'-dithiobenzoic acid (5) (0.213 g, 0.696 mmol),
and 10 µL of DMF was added to it. The solution was cooled to 0 oC, and slowly oxalyl
chloride (48) (0.883 g, 6.96 mmol) was added into the solution via syringe. The solution
was stirred for 3 h and then reduced under pressure to give a yellow oil. Yellow oil was
dissolved in 6 mL of CH2Cl2 and then transferred to a flask containing triethylene glycol
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O
Cl

S
2

COOH

2

O

DMF, THF

COCl

ortho = 47

ortho = 49

para = 5

para = 55

mS

2
ortho, m = 0, 1, 2, 3
para, m = 1, 2, 3

S
48

O

HO

Cl

S

Et3N, CH2Cl2

O

O

mS

O

ortho = 50, 37, 38, 45
para = 37, 38, 45

n

ortho, m = 0, 1, 2, 3
para, m = 1, 2, 3
ortho = 51, 52, 53, 54
para = 56, 57, 58

disulfide (38) (0.981 g, 2.98 mmol), Et3N (0.77 mL, 5.57 mmol), and 46 mL of CH2Cl2 at
0 oC. The reaction mixture was stirred at 0 oC for 30 min and gradually warmed to room
temperature, and then stirring continued overnight. The reaction mixture was dissolved in
50 mL of CH2Cl2 and then washed with 50 mL of 0.1 N HCl. The organic layer was then
washed with water (2 x 50 mL), dried (MgSO4), filtered, and reduced under pressure to
give 0.81 g of a polymer (57).
3.2.4 Reduction of ortho- and para-substituted aromatic ethylene glycol dithiol
polymer with dithiothreitol (DTT)

S
SH
DTT, Et3N
O

O

mS

O

n

O

Overall yield

O

m SH

O
ortho, m = 0, 1, 2, 3
para, m = 1, 2, 3

ortho - 46%,30%, 63%, 58%
para - 95%, 59%, 68%

ortho = 51, 52, 53, 54

ortho, m = 0, 1, 2, 3
para, m = 1, 2, 3
ortho = 9, 10, 11, 12
para = 13, 14, 15

para = 56, 57, 58
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General procedure
Triethylamine (0.5 mL, 3.59 mmol) and DTT (1.032 g, 6.70 mmol) were added to
a concentrated solution of a polymer (57) (0.81 g) in 15 mL of CH2Cl2. The reaction
mixture was stirred for 2 h and 3 h for triethylene glycol polymer and tetraethylene glycol
polymer, respectively, under argon and then the mixture was extracted with 50 mL of
ethyl acetate. The organic layer was washed with water (2 x 50 mL), dried over MgSO4,
filtered, and concentrated under reduced pressure to give the crude product. The crude
product was then purified by silica gel chromatography using CH2Cl2: hexane (2:1 for
monoethylene glycol dithiol and diethylene glycol dithiol, 4:1 for triethylene glycol
dithiol, and 6:1 for tetraethylene glycol dithiol) to give 0.124 g of a para-substituted
aromatic triethylene glycol dithiol (14) as yellow oil , 59% overall yield.
2-mercaptoethyl-2-mercaptobenzoate [ortho-substituted aromatic monoethylene
glycol dithiol (9)]: 46 % overall yield, 1H NMR (CDCl3, 400 MHz) δ 8.04 (d, J = 7.4 Hz,
1H), 7.33 - 7.30 (m, 2H), 7.17 (ddd, J = 8.0, 6.0, 2.5 Hz, 1H), 4.61 (s, 1H), 4.45 (t, J =
6.6 Hz, 2H), 2.90 (dt, J = 8.5, 6.6 Hz, 2H), 1.59 (t, J = 8.6 Hz, 1H); 13C NMR (CDCl3,
100 MHz) δ 166.4, 138.5, 132.8, 131.9, 131.1, 125.8, 124.9, 66.6, 23.5.
2-(2-mercaptoethoxy)ethyl-2-mercaptobenzoate

[ortho-substituted

aromatic

diethylene glycol dithiol (10)]: 30% overall yield, 1H NMR (CDCl3, 400 MHz) δ 8.05
(d, J = 8.5 Hz, 1H), 7.32 - 7.30 (m, 2H), 7.16 (ddd, J = 8.1, 5.8, 2.8 Hz, 1H), 4.66 (s,
1H), 4.48 (t, J = 4.7 Hz, 2H), 3.81 (t, J = 4.8 Hz, 2H), 3.66 (t, J = 6.3 Hz, 2H), 2.71 (dt, J
= 8.1, 6.3 Hz, 2H), 1.60 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 166.7, 134.4,
132.7, 132.0, 131.0, 129.6, 124.8, 72.9, 68.9, 64.3, 24.5.
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2-[2-(2-mercaptoethoxy)ethoxy]ethyl-2-mercaptobenzoate

[ortho-substituted

aromatic triethylene glycol dithiol (11)]: 63% overall yield, 1H NMR (CDCl3, 400
MHz) δ 8.03 (d, J = 7.6 Hz, 1H), 7.30 - 7.28 (m, 2H), 7.13 (ddd, J = 8.1, 5.6, 2.9 Hz,
1H), 4.67 (s, 1H), 4.46 (t, J = 4.8 Hz, 2H), 3.82 (t, J = 4.8 Hz, 2H), 3.69 - 3.57 (m, 6H),
2.66 (dt, J = 8.2, 6.5 Hz, 2H), 1.55 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ
166.7, 138.3, 132.6, 131.93, 130.9, 126.0, 124.7, 73.0, 70.7, 70.3, 69.2, 64.3, 24.4.
HRMS (ESI+) calcd for C13H18O4S2 (M + Na)+ 325.05442, obsd 325.0536, (M + H)+
303.0724, obsd 303.0718.
2-[2-(2-(2-mercaptoethoxy)ethoxy)ethoxy]ethyl-2-mercaptobenzoate

[ortho-

substituted aromatic tetraethylene glycol dithiol (12)]: 58% overall yield, 1H NMR
(CDCl3, 400 MHz) δ 8.03 (d, J = 7.5 Hz, 1H), 7.31 - 7.29 (m, 2H), 7.15 (ddd, J = 8.1,
5.6, 3.0 Hz, 1H), 4.70 (s, 1H), 4.47 (t, J = 4.8 Hz, 2H), 3.83 (t, J = 4.8 Hz, 2H), 3.70 3.57 (m, 10H), 2.67 (dt, J = 8.2, 6.5 Hz, 2H), 1.57 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3,
100 MHz) δ 166.7, 138.7, 132.6, 132.0, 131.0, 126.1, 124.8, 73.0, 70.8, 70.8, 70.7, 70.4,
69.2, 64.4, 24.4. HRMS (ESI+) calcd for C15H22O5S2 (M + Na)+ 369.0806, obsd.
369.0788
2-(2-mercaptoethoxy)ethyl-4-mercaptobenzoate

[para-substituted

aromatic

diethylene glycol dithiol (13)]: 95% overall yield, 1H NMR (CDCl3, 400 MHz) δ 7.90
(d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.45 (t, J = 4.7 Hz, 2H), 3.79 (t, J = 4.8 Hz,
2H), 3.67 - 3.62 (m, 2H), 2.70 (dt, J = 8.1, 6.3 Hz, 2H), 1.59 (t, J = 8.2 Hz, 1H);

13

C

NMR (CDCl3, 100 MHz) δ 166.1, 138.7, 130.4, 128.2, 127.1, 72.9, 69.0, 64.1, 24.4.
HRMS (ESI+) calcd for C11H14O3S2 (M + Na)+ 281.0282, obsd 281.0289.
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2-(2-(2-mercaptoethoxy)ethoxy)ethyl-4-mercaptobenzoate

[para-substituted

aromatic triethylene glycol dithiol (14)]: 59% overall yield, 1H NMR (CDCl3, 400
MHz) δ 7.90 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.46 (t, J = 4.8 Hz, 2H), 3.83
(t, J = 4.8 Hz, 2H), 3.71 - 3.60 (m, 6H), 2.68 (dt, J = 8.1, 6.4 Hz, 2H), 1.58 (t, J = 8.2
Hz, 1H);

13

C NMR (CDCl3, 100 MHz) δ 166.1, 138.6, 130.4, 128.2, 127.1, 73.0, 70.7,

70.3, 69.3, 64.1, 24.4. HRMS (ESI+) calcd for C13H18O4S2 (M + Na)+ 325.0544, obsd
325.0538, C13H18O4S2 (M + H)+ 303.0724, obsd 303.0721.
2-[2-(2-(2-mercaptoethoxy)ethoxy)ethoxy]ethyl-4-mercaptobenzoate

[para

-

substituted aromatic tetraethylene glycol dithiol (15)]: 68% overall yield, 1H NMR
(CDCl3, 400 MHz) δ 7.90 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.45 (t, J = 4.8
Hz, 2H), 3.82 (t, J = 4.8 Hz, 2H), 3.71 - 3.58 (m, 10H), 2.68 (dt, J = 8.1, 6.5 Hz, 2H),
1.59 (t, J = 8.2 Hz, 1H);

13

C NMR (CDCl3, 100 MHz) δ 166.1, 138.6, 130.4, 128.2,

127.2, 73.0, 70.8, 70.8, 70.7, 70.3, 69.3, 64.2, 24.4. HRMS (ESI+) calcd for C15H22O5S2
(M + Na)+ 369.0806, obsd 369.0807.

3.3 Synthesis of aromatic triethylene glycol monothiol (61)126
3.3.1 Synthesis of aromatic triethylene glycol disulfide (60)
HO

O

m S

m=2
38
COCl

2

O
Et3N, CH2Cl2

O

O

14%

S
m

2

m=2

59

60

Benzoyl chloride (59) (0.646 g, 4.62 mmol) was dissolved in 20 mL of CH2Cl2
and then transferred to a flask containing triethylene glycol disulfide (38) (0.763 g, 2.31

59

mmol), Et3N (0.964 mL, 6.93 mmol), and 10 mL of CH2Cl2 at 0 oC. The reaction mixture
was stirred at 0 oC for 30 min and then gradually warmed to room temperature, and
stirring continued overnight. The reaction mixture was dissolved in 30 mL CH2Cl2 and
then washed with 50 mL of 0.1 N HCl. The organic layer was then washed with water (2
x 30 mL), dried (MgSO4), filtered, and reduced under pressure to give the crude oil. The
crude oil was the purified by flash chromatography using 4:1 hexane:EtOAc to give 0.17
g of a yellow oil (60), 14% yield.
1

H NMR (CDCl3, 400 MHz) δ 8.05 (d, J = 7.1 Hz, 4H), 7.54 (t, J = 7.4 Hz, 2H), 7.43 (t J

= 7.9 Hz, 4H), 4.47 (t, J = 4.8 Hz, 4H), 3.83 (t, J = 4.9 Hz, 4H), 3.74 - 3.63 (m, 12H),
2.86 (t, J = 6.7 Hz, 4H).
3.3.2 Synthesis of aromatic triethylene glycol monothiol (61)

DTT, Et3N
O
O

O

S
m

2

CH2Cl2
57%

m=2

O

O

O

SH
m

m=2

60

61

Triethylamine (0.20 mL, 1.43 mmol) and DTT (0.124 g, 0.315 mmol) were added
to the disulfide (60) (0.17 g) in 15 mL of CH2Cl2. The reaction mixture was stirred for 2 h
under argon and then the mixture was extracted with ethyl acetate. The organic layer was
washed with water (2 x 25 mL), dried over MgSO4, filtered, and concentrated under
reduced pressure to give the crude product. The crude product was then purified by silica
gel chromatography using CH2Cl2 to give 0.097 g of aromatic triethylene glycol
monothiol (61) as an yellow oil, 57% overall yield.

60

1

H NMR (CDCl3, 400 MHz) δ 8.04 (d, J = 7.0 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (t J

= 7.7 Hz, 2H), 4.47 (t, J = 4.8 Hz, 2H), 3.83 (t, J = 3.7 Hz, 2H), 3.70 (t, J = 4.0 Hz, 2H),
3.65 - 3.58 (m, 4H), 2.66 (q, J = 6.4 Hz, 2H), 1.55 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3,
100 MHz) δ 166.6, 133.1, 130.2, 129.8, 128.4, 73.0, 70.8, 70.4, 69.4, 64.2, 24.4. HRMS
(ESI+) calcd for C13H18O4S (M + Na)+ 293.08235, obsd 293.08230.
3.4 Synthesis of Di quaternary salt dithiols (Di QAS 16 and 17)
3.4.1 Synthesis of N1,N3-bis(4-benzoylthio)benzyl)-N1,N1,N3,N3-tetramethylpropane1,3-diaminium bromide (67)127

O

O

N

S

m

O

N
S

S

m = 0, 1, 2, 4
62, 63, 64, 65
CH3CN
Br

99%, 95%, 96%, 99%

25

N
Br

m

N

Br

m = 0, 1, 2, 4
66, 67, 68, 69

General procedure
Benzyl bromide derivative (25) (2.10 g, 6.84 mmol) was added to a stirred
solution of N,N,N',N'-tetramethyl-1,3-propane diamine (63) (0.38 g, 2.92 mmol) in 20 mL
of acetonitrile. The reaction mixture was stirred overnight, then the slurry was diluted
with diethyl ether, filtered, washed with diethyl ether, and dried yielding 2.07 g of a
white powder (67), 95% yield.
N1,N2-bis(4-benzoylthio)benzyl)-N1,N1,N2,N2-tetramethylethane-1,2-diaminium
bromide [TMEDA Salt (66)]: 99% yield, 1H NMR (DMSO, 400 MHz) δ 8.00 (d, J =
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7.5 Hz, 4H), 7.82 - 7.72 (m, 10H), 7.62 (t, J = 7.8 Hz, 4H), 4.82 (s, 4H), 4.16 (s, 4H),
3.17 (s, 12H). 13C NMR (DMSO, 100 MHz) δ 188.4, 135.6, 135.2, 134.6, 134.0, 129.8,
129.4, 128.8, 127.1, 66.7, 55.8, 49.8.
N1,N3-bis(4-benzoylthio)benzyl)-N1,N1,N3,N3-tetramethylpropane-1,3-diaminium
bromide [Propane salt (67)]: 95% yield, 1H NMR (DMSO, 400 MHz) δ 8.00 (d, J = 7.4
Hz, 4H), 7.78 - 7.70 (m, 10H), 7.62 (t, J = 7.8 Hz, 4H), 4.74 (s, 4H), 3.37 (t, J = 8.0 Hz,
4H), 3.11 (s, 12H), 2.50 - 2.46 (m, 2H).

13

C NMR (DMSO, 100 MHz) δ 188.6, 135.7,

135.2, 134.6, 134.0, 129.6, 129.5, 129.3, 127.2, 66.5, 60.1, 49.7, 16.9. HRMS (ESI+)
calcd for C35H40Br2N2O2S2 (M - Br)+ 663.1714, obsd 663.1685.
N1,N4-bis(4-benzoylthio)benzyl)-N1,N1,N4,N4-tetramethylbutane-1,4-diaminium
bromide [Butane salt (68)]: 96% yield, 1H NMR (DMSO, 400 MHz) δ 7.99 (d, J = 7.2
Hz, 4H), 7.79 - 7.70 (m, 10H), 7.62 (t, J = 7.9 Hz, 4H), 4.66 (s, 4H), 3.39 (brs, 4H), 3.04
(s, 12H), 1.84 (brs, 4H).

13

C NMR (DMSO, 100 MHz) δ 188.4, 135.6, 135.2, 134.5,

133.8, 129.5, 129.4, 129.4, 127.1, 66.1, 62.6, 49.4, 19.3. HRMS (ESI+) calcd for
C36H42Br2N2O2S2 (M - Br)+ 677.1871, obsd 677.1849
N1,N6-bis(4-benzoylthio)benzyl)-N1,N1,N6,N6-tetramethylhexane-1,6-diaminium
bromide [Hexane salt (69)]: 99% yield, 1H NMR (DMSO, 400 MHz) δ 7.99 (d, J = 7.3
Hz, 4H), 7.79 - 7.69 (m, 10H), 7.62 (t, J = 7.9 Hz, 4H), 4.67 (s, 4H), 3.33 (brs, 4H), 3.03
(s, 12H), 2.07 (brs, 4H), 1.38 (brs, 4H).

13

C NMR (DMSO, 100 MHz) δ 188.5, 135.6,

135.1, 134.5, 133.8, 129.5, 129.3, 127.1, 65.5, 63.5, 49.3, 25.3, 21.7. HRMS (ESI+) calcd
for C38H46Br2N2O2S2 (M - Br)+ 705.2184, obsd 705.2163.
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3.4.2 Synthesis of N1,N3-bis(4-mercaptobenzyl)-N1,N1,N3,N3-tetramethylpropane-1,3diaminium bromide (Di QAS 16)
O
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S

SH

SH

1:1 HBr:H2O
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Br

N

m

N
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m = 1, 4

m = 1, 4

67, 69

16, 17

N

Br

General procedure
The di quaternary ammonium salt (67) (1.557 g, 2.09 mmol) dissolved in 45 mL
of water and 45 mL of HBr (48 wt% in water) was refluxed under argon at 130 °C. After
90 min, the reaction mixture was cooled to 0 °C, filtered, and then washed with EtOAc (3
x 100 mL). The aqueous layer was reduced partially and then lyophilized several times
by dissolving the residue in water to give 1.042 g of Di QAS 16 as a white powder, 93%
yield.
N1,N3-bis(4-mercaptobenzyl)-N1,N1,N3N3-tetramethylpropane-1,3-diaminium
bromide (Di QAS 16): 93% yield, 1H NMR (D2O, 400 MHz) δ 7.46 (d, J = 8.4 Hz, 4H),
7.41 (d, J = 8.4 Hz, 4H), 4.52 (s, 4H), 3.37 (t, J = 8.3 Hz, 4H), 3.09 (s, 12H), 2.41
(quintet, J = 8.3 Hz, 2H). 13C NMR (D2O, 100 MHz) δ 135.8, 133.5, 129.0, 123.5, 68.5,
60.1, 49.7, 17.0. HRMS (ESI+) calcd for C21H32Br2N2S2 (M - Br)+ 455.1190, obsd
455.1175.
N1,N6-bis(4-mercaptobenzyl)-N1,N1,N3N6-tetramethylhexane-1,3-diaminium
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bromide (Di QAS 17): 51% yield, 1H NMR (D2O, 400 MHz) δ 7.50 (d, J = 7.2 Hz, 4H),
7.45 (d, J = 7.7 Hz, 4H), 4.48 (s, 4H), 3.30 (t, J = 8.0 Hz, 4H), 3.08 (s, 12H), 1.92 (brs,
4H), 1.47 (brs, 4H). 13C NMR (D2O, 100 MHz) δ 135.3, 133.4, 128.9, 124.1, 67.4, 63.8,
49.6, 25.2, 22.0. HRMS (ESI+) calcd for C24H38Br2N2S2 (M - Br)+ 497.1659, obsd
497.1638.
3.5 Enzymatic assays
3.5.1 Preparation of reduced denatured lysozyme
Lysozyme (20 mg/mL) was dissolved in 0.1 M Tris-HCl at pH 8.6 which
contained 6 M Gdn HCl and 0.15 M dithioerythritol (DTE). The protein solution was
incubated for 2 h at room temperature and then acidified with glacial acetic acid to pH
3.59,128 The solution was then applied to a column packed with Sephadex G-25 that has
been pre-equilibrated with 0.1 M acetic acid. The fractions that contained reduced
lysozyme, as determined by Ellman’s reagent [100 mg of (5,5'-dithiol-bis(2-nitrobenzoic
acid)) was dissolved in 25 mL of 0.2 M Tris-HCl, pH 8.0, and 25 mL of ethanol], were
collected and mixed together in a 50 mL centrifuge tube. The fractions containing DTE,
which eluted from the column after the protein, were discarded. The reduced protein
concentration was determination by its absorbance at 280 nm using a Cary 300 UVvisible spectrophotometer (ε280 nm = 2.37 mL mg-1cm-1).129 The reduced lysozyme showed
no enzymatic activity. The reduced lysozyme was stored at -20 oC as a solid after the
removal of solvent by lyophilization.
3.5.2 Calibration of assay for native lysozyme
Native lysozyme was dissolved in Gdn HCl buffer (6 M Gdn HCl dissolved in 0.1
M acetic acid) to prepare a stock solution of native lysozyme (approx. 1 mg/mL). The
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concentration of the stock solution was determined spectrophotometrically by measuring
the absorbance at 280 nm (ε280 nm = 2.63 mL mg-1 cm-1).129,130 The stock solution of native
lysozyme was then used to prepare solutions of various concentrations, from 0.01 mg/mL
to 0.1 mg/mL. The enzymatic assay (vide infra) was then used to determine the activity
of each solution. The activity was then plotted against native protein concentration. It was
observed that the rate varied linearly with respect to protein concentration.
3.5.3 Assay for lysozyme activity129,131,132
In order to measure the lysozyme activity in all cases, a 20 L aliquot of native or
renatured lysozyme solution (0.1 mg/mL) was mixed with 980 L of M. Lysodeikticus
solution (0.25 mg/mL) in 66 mM monobasic potassium phosphate, pH 6.2, equilibrated at
25 C. The cuvette was inverted repeatedly for 15 s to ensure proper mixing of the
samples, and then light scattering at 450 nm was monitored for 2 min. The lytic activity
of lysozyme was determined from the slope of the line.
3.5.4 Refolding of denatured reduced lysozyme (0.1 mg/mL)
Reduced lysozyme (10 mg/mL) was dissolved in 0.1 M acetic acid containing 6
M Gdn HCl at pH 2.5 (280nm = 2.37 mL mg-1 cm-1).59,129,131 The pH of the stock solutions
containing the thiol or disulfide were also adjusted to the appropriate pH (7.0 or 8.0) with
1 M KOH prior to use. Refolding of reduced lysozyme was carried out in a deoxygenated
renaturation buffer [0.1 M bis tris propane-HCl, pH 7.0, 1 mM EDTA, and 0.5 M Gdn
HCl or 0.1 M Tris-HCl, pH 8.0, 1 mM EDTA, and 0.5 M Gdn HCl, and various
concentrations of GSH or aromatic dithiols, and GSSG or aromatic disulfide]. In a 1.5
mL-Eppendorf tube, 10 L of reduced lysozyme (10 mg/mL) was added to 990 L of
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renaturation buffer (100-fold dilution). For reproducible mixing conditions, the
renaturation buffer was placed in an Eppendorf tube, the protein was added as a droplet
on the wall of the tube above the buffer meniscus, and mixing was achieved by vigorous
agitation with a vortex mixer for 15 s. Subsequently, 20 L aliquots were removed at
specific times and assayed for enzymatic activity. All the refolding experiments were
performed at 25 C.
3.5.5 Refolding of denatured reduced lysozyme (1 mg/mL)
Reduced lysozyme (11 mg/mL) was dissolved in 0.1 M acetic acid containing 6
M Gdn HCl at pH 2.5. The pH of the protein solution was then adjusted to that of the
folding experiment (pH 7.0 or 8.0) by the addition of 3 M KOH. After adjusting the pH,
the concentration of the protein solution was determined by UV-vis, and the final
concentration was adjusted to 10 mg/mL with 6 M Gdn HCl, if necessary (280nm = 2.37
mL mg-1 cm-1).59,129,131 Stock solutions of GSH, aromatic monothiols, aromatic dithiols,
and GSSG were prepared in deoxygenated 0.1 M bis tris propane-HCl (for pH 7.0) or 0.1
M Tris-HCl (for pH 8.0), 1.25 M Gdn HCl, and 1 mM EDTA. From the stock solutions,
varying amount of GSH and GSSG, aromatic monothiol and GSSG, or aromatic dithiols
and GSSG were mixed in 0.1 M bis tris propane-HCl at pH 7.0 or 0.1 M Tris-HCl at pH
8.0, 1.25 M Gdn HCl, and 1 mM EDTA and adjusted to the appropriate pH with 1 M
KOH, if necessary (renaturation buffer). In a 1.5 mL-Eppendorf tube, 900 L of
renaturation buffer was mixed with 100 L of reduced lysozyme solution (10 mg/mL) to
give a 10 fold dilution. Subsequently, at specific intervals, 10 L of aliquots were
withdrawn and diluted with 90 L of buffer (0.1 M bis tris propane-HCl at pH 7.0 or 0.1

66

M Tris-HCl at pH 8.0, 1.25 M Gdn HCl, and 1 mM EDTA) followed by withdrawing 20
L of the resulting solution and then measuring the enzymatic activity.
3.6 Determination of pKa values (UV-Vis method)133,134
Twenty four buffers (50 mM) at a range of pH values: glycine, pH 2.5, 3.0, 3.3;
2,2-dimethoxysuccinate, pH 3.7, 4.0, 4.3, 4.7, 5.0, 5.3, 5.7, 6.0, 6.3, 6.7; Tris, pH 7.0, 7.3,
7.7, 8.0, 8.3, 8.7; glycine, pH 9.0, 9.5, 10.0, 10.5; H3PO4, pH 11.0 were prepared. An
ethanolic solution (100 mM) of the aromatic thiol or dithiol was diluted by 100-1000 fold
using a high or low pH buffer until the absorbance was 1.5. Then the absorbance of the
given aromatic thiol or dithiol was measured in buffers whose pH would fall within 1.5
units of the pKa of the thiol tested. The absorbance of the selected thiol or dithiol in each
buffers was measured at the λmax, of the corresponding thiolate or thiol. The absorbance
was plotted against the pH and then compared with a plot derived from theory. The pKa
was determined from the best fit curve.
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Chapter 4

Results and discussion
Results and discussion will be divide into four section.
1) The synthesis of aromatic monothiols and their corresponding disulfides will be
described. Additionally, the folding of bovine pancreatic trypsin inhibitor (by Ms. Shweta
Mandumula) and the folding of lysozyme (by Dr. David Madar) using aromatic
monothiols and their corresponding disulfides will be presented.
2) The synthesis of ortho- and para-substituted aromatic ethylene glycol dithiols and
their effect on the folding of lysozyme (0.1 mg/mL) will be discussed.
3) The synthesis of quaternary ammonium aromatic dithiols and the activity of these
compounds on the folding of lysozyme (1 mg/mL) will be discussed.
4) The thiol pKa values of aromatic monothiols and dithiols will be presented.
4.1 Synthesis of aromatic monothiols (1-4) and their corresponding disulfides (5-8),
and their folding studies
Initially, a series of aromatic monothiols with a range of thiol pKa values, such as
4-mercaptobenzoic

acid

(1),

4-mercaptobenzylphosphonic

acid

(2),

quaternary

ammonium salt (3), and 4-mercaptobenzenesulfonic acid (4), and their corresponding
disulfides (5-8) were synthesized. The above compounds were synthesized on a
multigram scale in 4-5 steps. Compounds 1-4 were selected on the basis of their thiol pKa
values (5-7) and water solubility (>10 mM). The pKa value of the aromatic thiols were
expected to be similar to that of PDI.135 As most protein folding assays are performed in
aqueous media close to neutral pH, the aromatic thiols selected were expected to be
soluble at pH 7 in both the thiol and disulfide form.
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4.1.1 Synthesis of 4-mercaptobenzoic acid (1) and its disulfide (5)
The synthesis of 4-mercaptobenzoic acid (1) was performed from readily
available methyl 4-hydroxybenzoate (18). Methyl 4-hydroxybenzoate (18) on treatment
with DABCO and N,N-dimethylthiocarbamoyl chloride (19) gave compound (20) which
on heating at 210-240 oC underwent rearrangement to form compound (21). Next,
compound (21) was hydrolyzed by treating with NaOH and methanol to give 4mercaptobenzoic acid (1) (Scheme 3). The disulfide of 4-mercaptobenzoic acid (5) was
synthesized by dissolving 4-mercaptobenzoic (1) acid in ethanol and adding a saturated
solution of I2 in 95% ethanol until a light yellow color persisted. The mixture was filtered
to give 4-mercaptobenzoic acid disulfide (5) as an off white solid (Scheme 3).
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Scheme 3. Synthesis of 4-mercaptobenzoic acid (1) and its disulfide (5)
4.1.2 Synthesis of 4-mercaptobenzylphosphonic acid (2)
The 4-mercaptobenzylphosphonic acid (2) and quaternary ammonium salt (3)
were synthesized through a common intermediate, bromo derivative (25). 4-
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Mercaptobenzylphosphonic acid (2) was synthesized by treating p-toluene thiol (22) with
benzoyl chloride (23) to form compound (24). Compound (24) was then treated with Nbromosuccimide to form bromo derivative (25) which on treatment with triethylphosphite
produced phosphonic acid derivative (26). Previously, phosphonic acid derivative (26)
was purified by column chromatography followed by recrystallization. I improved upon
this method by cooling the reaction mixture to - 5 oC, which precipitated out the product.
The solid residue was then recrystallized to yield the phosphonic acid (26). By avoiding
the column chromatography step, I saved time, improved the yield, and was able to
perform the reaction on a large scale. Phosphonic acid derivative (26) was then reacted
EtO
Br
CH3

CH3
NBS, h

NEt3/toulene
78%
SH

S

O

Cl

EtO
EtO

P

HO
HO

2) Ac2O
94%

P

O

27

HO
HO

P

O

O2

78%
S

26

O

HCl, 

O

Ph

25

O

1) NaOEt/EtOH

S

69%

O

Ph

24

23

O

105 oC

69%
S

O

P

P(OEt)3

Ph
22

EtO

83%
SH

S

2

6

2

Scheme 4. Synthesis of 4-mercaptobenzylphosphonic acid (2) and its disulfide (6)
with sodium ethoxide/ethanol followed by acetic anhydride to change the benzoyl
protecting group to an acetyl protecting group, thus preventing benzoic acid from
precipitating out of the solution along with the 4-mercaptobenzylphosphonic acid (2) in
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the next step. Next, the acetyl protected group was hydrolyzed by refluxing with conc
HCl to give 4-mercaptobenzylphosphonic acid (2) (Scheme 4). The disulfide of 4mercaptobenzylphosphonic acid (6) was synthesized for the first time by vigorously
stirring the corresponding thiol (2) in water for 1 week (Scheme 4).
4.1.3 Synthesis of quaternary ammonium thiol salt (Mono QAS 3) and its disulfide 7
Mono QAS 3 was synthesized from bromo derivative (25), one of the
intermediates in the synthesis of 4-mercaptobenzylphosphonic acid (2). The bromo
derivative (25) was reacted with trimethylamine to form quaternary ammonium salt (28)
in 81% yield, which on hydrolysis with conc HBr:H2O (1:5) gave quaternary ammonium
thiol (3) in quantitative yield (Scheme 5). The disulfide of the quaternary ammonium salt
(7) was synthesized by vigorously stirring the corresponding thiol (3) in water for 6
months (Scheme 5).
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Scheme 5. Synthesis of Mono QAS (3) and its disulfide (7)
4.1.4 Synthesis of 4-mercaptobenzenesulfonic acid (4) and its disulfide (8)
The 4-Mercaptobenzenesulfonic acid (4) was synthesized from readily available
4-aminobenzenesulfonic acid (29). 4-Aminobenzenesulfonic acid (29) was dissolved in a
solution of NaOH in water, and then conc HCl was added. To the resulting suspension, a
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solution of sodium nitrite in water was added, and the mixture was poured into a solution
of sodium disulfide. The insoluble material was filtered off and a solution of aniline and
conc HCl in water was added to the filtrate. The precipitate was filtered, recrystallized
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Scheme 6. Synthesis of 4-mercaptobenzenesulfonic acid (4) and disulfide of Na salt of 4mercaptobenzenesulfonic acid (8)
from water, and washed with ethanol and hexane to give the dianilinium salt (30). The
dianilinium ions (30) were exchanged for hydrogen ions by ion exchange
chromatography, and then the disulfide (31) was reduced by treating with
triphenylphosphine

in
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mercaptobenzenesulfonic acid (8) was formed as its sodium salt by exchanging the
anilinium ions (30) with sodium ions by ion exchange chromatography (Scheme 6 ).
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4.1.5 Folding studies with aromatic monothiols and their disulfides
4.1.5.1 Folding of BPTI in the presence of GSSG, phosphonic acid disulfide (6),
quaternary ammonium salt disulfide (7), and sulfonic acid disulfide (8)
A folding intermediate of BPTI, N*, was folded in the presence of various
concentrations of GSSG and more reactive small molecule aromatic disulfides (6), (7),
and (8) by Ms. Shweta Mandumula (Figure 18 a-c). It was observed that the folding rate
increased as the thiol pKa of the corresponding thiol decreased. As aromatic thiols have
lower thiol pKa values, aromatic thiols act as better leaving group than GSH during
thiol/disulfide interchange reactions. It was also observed that by increasing the disulfide
concentration the folding rate of N* increased.
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Figure 18. HPLC chromatograms of a folding mixture of BPTI at different time intervals
in the presence of (a) 10 mM GSSG, (b) 0.25 mM phosphonic acid disulfide (6), and (c)
0.25 mM sulfonic acid disulfide (8).
Creighton and Kim proposed folding models for BPTI which indicated that N*
does not undergo direct oxidation to native protein, but rearranges to N' and then
NSH.40,93,136 N' and then NSH are subsequently oxidized to native protein. However, the
above results shows that N* does undergoes direct oxidation to N. Furthermore, the
results demonstrate that small molecule aromatic disulfides enhance the folding rate
constants of N* to N by 100-3000 fold as compared to GSSG.
4.1.5.2 Folding of lysozyme with aromatic monothiols (2 and 3) and their
corresponding disulfides (6 and 7)
All in vitro folding experiments with lysozyme were performed at pH 7.0 or 8.0
and at a higher protein concentration (1 mg/mL) than traditionally used (0.1 mg/mL). In
vitro folding was carried out using various concentrations of phosphonic acid monothiol
(2) and its disulfide (6) or quaternary ammonium salt (3) and its disulfide (7) in
comparison with 7 mM GSH and 2 mM GSSG by Dr. David Madar. At pH 7.0, aromatic
thiol (2) and its disulfide (6) or aromatic thiol (3) and its disulfide (7) increased the
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folding rate up to 11 times and improved the yields between 20 and 40% as compared to
GSH/GSSG. At pH 8.0, aromatic thiol (2) and its disulfide (6) or aromatic thiol (3) and
its disulfide (7) increased the folding rate up to 7 times and improved the yields up to
25% as compared to GSH/GSSG (Figure 19 a-d).
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Figure 19. Folding of lysozyme at 1mg/mL (a) At pH 7.0 with (▲) 2 mM 2/1 mM 6, (■)
5 mM 2/1 mM 6, (♦) 10 mM 2/1 mM 6, (●) 20 mM 2/1 mM 6, and (▼) 7 mM GSH/2
mM GSSG. (b) At pH 8.0 with (▲) 10 mM 2/0.5 mM 6, (■) 20 mM 2/0.5 mM 6, (♦) 10
mM 2/1 mM 6, (●) 20 mM 2/1 mM 6, and (▼) 7 mM GSH/2 mM GSSG. (c) At pH 7.0
with (▲) 10 mM 3/0.5 mM 7, (■) 20 mM 3/0.5 mM 7, (♦) 20 mM 3/1 mM 7, (●) 20 mM
3/2 mM 7, and (▼) 7 mM GSH/2 mM GSSG. (d) At pH 8.0 with (▲) 10 mM 3/1 mM 7,
(■) 20 mM 3/1 mM 7, (♦) 20 mM 3/2 mM 7, (●) 50 mM 3/2 mM 7, and (▼) 7 mM
GSH/2 mM GSSG.
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4.2 Synthesis of aromatic dithiols (9-15)
The aim of the project was to increase the in vitro folding rates and yields of
disulfide containing proteins by combining the advantageous properties of aliphatic
dithiols and aromatic monothiols. Raines et al. have demonstrated that aliphatic dithiols
increase the in vitro folding yield of RNase A relative to aliphatic monothiols, while Lees
et al. have shown that aromatic monothiols increase in vitro folding rates of RNase A and
lysozyme relative to aliphatic monothiols.4,32,35,38,117 Thus, I planned to synthesize dithiols
containing an aromatic thiol group. The compounds were designed to mimic PDI, such
that one thiol group is more reactive than the other. Hence, the more reactive thiol group
was present on an aromatic ring and the other less reactive thiol group was on an aliphatic
chain. Additionally, the compounds should be aqueous soluble from pH 6.0 to 8.0, the pH
range used to fold most proteins in vitro. Therefore, polyethylene groups were inserted
into the aliphatic chain to improve solubility. Furthermore, ortho- and para-substituted
aromatic ethylene glycol dithiols were selected to provide a wide range of thiol pKa
values (5-7). The ortho- and para- substituted aromatic ethylene glycol dithiols consisted
of one thiol group on the aromatic ring and a second thiol group on the free end of a
polyethylene glycol chain. The aliphatic chain of polyethylene glycol was connected to
the aromatic ring via an esterification reaction.
4.2.1 Synthesis of ortho- and para-substituted aromatic ethylene glycol dithiols (915)
To synthesizes ortho- and para- series of aromatic ethylene glycol dithiols (9-15),
ethylene glycol disulfides (37, 38, and 45) were synthesizes first. Ethylene glycol
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disulfides (37, 38, and 45) were prepared as shown below. These ethylene glycol
disulfides (37, 38, and 45) were then treated with acid chloride (49) to prepare orthosubstituted aromatic ethylene glycol dithiols or acid chloride (55) to prepare parasubstituted aromatic ethylene glycol dithiols.
4.2.1.1 Synthesis of di-, tri-, tetra- and hexaethylene glycol disulfides (37, 38, 45, and
46)
Treatment of di- and triethylene glycol chlorides (33) and (34) with thiourea (32)
followed by hydrolysis with NaOH gave di- and triethylene glycol thiols (35) and (36),
respectively. Thiols (35) and (36) were then subjected to air oxidation for 1 week to give
the corresponding disulfides (37) and (38), respectively, (Scheme 7). Tetra- and
hexaethylene glycol disulfides, (45) and (46), were prepared by treating tetra- and
hexaethylene glycol, (39) and (40), respectively, with p-toluenesulfonyl chloride to form
S
H2N

NH2
1) reflux

32

HO
HO

2) NaOH
3) HCl

O
m
m = 1, 2

O

Cl

59%, 67%

O2
m SH

HO

O
m

45%, 84%

m = 1, 2

m = 1, 2

35, 36

37, 38

S
2

33, 34

Scheme 7. Synthesis of di- and triethylene glycol disulfides (37 and 38)
their respective monotosylates (41) and (42). The monotosylates (41) and (42) were then
treated with thiourea to form the tetra- and hexaethylene glycol thiols (43) and (44),
respectively. The tera- and hexaethylene glycol thiols, (43) and (44), were then subjected
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to air oxidation by stirring vigorously in water for 1 week to form the corresponding
disulfides (45) and (46), respectively (Scheme 8).
O
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m
2

m = 3, 5

m = 3, 5

43, 44
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Scheme 8. Synthesis of tetra- and hexaethylene glycol disulfides (45 and 46)
4.2.1.2 Synthesis of ortho-substituted aromatic mono-, di-, tri-, and tetraethylene
glycol dithiols (9-12)
O
S
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COOH

Cl
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2
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O
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DTT, Et3N
O

O

HO

CH2Cl2
Overall yield
46%, 30%, 63%, 58%

SH
O

O

O

SH
m

m = 0, 1, 2, 3
9, 10, 11, 12

51, 52, 53, 54

Scheme 9. Synthesis of ortho-substituted aromatic mono-, di-, tri-, and tetraethylene
glycol dithiols (9-12)
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The first step in the synthesis of ortho-substituted aromatic mono-, di-, tri-, and
tetraethylene glycol dithiols (9-12) involved the treatment of readily available
dithiosalicylic acid (47) with oxalyl chloride (48) and DMF in THF to produce an acid
chloride (49). In the same pot, the acid chloride (49) was then treated with mono-, di-, triand tetraethylene glycol disulfides (50, 37, 38, and 45) to form their respective polymer
(51-54). The polymers (51-54) was then reduced with DTT in the presence of a base,
Et3N, to give ortho-substituted aromatic mono-, di-, tri- and tetra ethylene glycol dithiols
(9-12), respectively, (Scheme 9).
4.2.1.3 Synthesis of para-substituted aromatic di-, tri-, and tetraethylene glycol
dithiols (13-15)
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O
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n

m = 1, 2, 3
56, 57, 58

S

SH
DTT, Et3N

CH2Cl2
O
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56, 57, 58

13, 14, 15

SH

Scheme 10. Synthesis of para-substituted aromatic di-, tri-, and tetraethylene glycol
dithiols (13-15)
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The para-substituted aromatic di-, tri-, and tetraethylene glycol dithiols (13-15)
were synthesized in the same manner as the ortho-substituted aromatic ethylene glycol
dithiols (Scheme 10). The only difference between the synthesis of the ortho- and paraseries of compounds was that the disulfide of 4-mercaptobenzoic acid (5) was used
instead of dithiosalicylic acid (47).
ortho- and para- Substituted aromatic dithiols (11, 12, 14, and 15) were then
examined for their ability to fold reduced lysozyme. Lysozyme was selected as this
enzyme has been extensively studied, and its folding pathway has been well
characterized.37,85,129,137-139 The folding of reduced lysozyme was carried out in the
presence of various concentrations of aromatic dithiols (11, 12, 14, and 15) in
combination with either 0.2 mM GSSG or 2 mM GSSG. These concentrations of GSSG
were selected as our previous results obtained with RNase A and lysozyme used 0.2 mM
or 2 mM GSSG.4,35-37 These folding experiments were then compared directly with 7 mM
GSH and 2 mM GSSG. These concentrations of GSH and GSSG were selected for the
folding experiments as they gave the best combination of folding rate and yield in our
previous study at 0.1 mg/mL lysozyme concntration.37 All the folding experiments were
carried out at pH 7.0 and 8.0, and 0.1 mg/mL (7 µM) lysozyme concentration at 25 oC.
The folding of lysozyme was followed using the recovery of enzymatic activity.
Reduced lysozyme (10 mg/mL), from which the dithioerythritol (DTE) had been
removed by gel permeation chromatography, was diluted 100-fold into renaturation
buffer containing 0.1 M buffer (bis tris propane-HCl for pH 7.0 or Tris-HCl for pH 8.0),
1 mM EDTA, 0.5 M guanidine hydrochloride (Gdn HCl), and redox buffer.131,140 The use
of EDTA was to prevent metal catalyzed air oxidation of thiols.129 To minimize protein
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aggregation during folding, Gdn HCl was added.27,131 At specific times, aliquots were
removed from the folding reaction and the enzymatic activity was determined by adding
the aliquots to a suspension of M. lysodeikticus.129,131,132 The decrease in light scattering
was monitored at 450 nm for 2 min. The change in light scattering per minute is
proportional to enzymatic activity.
4.2.1.4 Folding of lysozyme with ortho-substituted aromatic ethylene glycol dithiols
(11 and 12)
Initially a range of concentrations was examined to find the best concentrations of
dithiols (11 and 12) for the folding of lysozyme. At 20 mM, ortho-substituted aromatic
ethylene glycol dithiols (11 and 12) were only partially soluble in 0.1 M bis tris propaneHCl buffer (pH 7.0) and 0.1 M Tris-HCl buffer (pH 8.0). The solubility of dithiols (11
and 12) was determined by Ellman’s method.141 The solubility of ortho-substituted
aromatic tri- and tetraethylene glycol dithiols (11 and 12) was found to be 4 and 10 mM
at pH 7.0, respectively, and 10 and 20 mM at pH 8.0, respectively. Thus, the
concentrations of triethylene glycol dithiol (11) examined were in the range of 0.25 to 2
mM at pH 7.0 and 0.25 to 10 mM at pH 8.0, whereas that of tetraethylene glycol dithiol
(12) were in the range of 0.25 to 10 mM at both pH 7.0 and 8.0. The folding experiments
were then performed with tri- and tetraethylene glycol dithiols (11 and 12) in
combination with either 0.2 or 2 mM GSSG at pH 7.0 and pH 8.0 (Tables 1 and 2,
Figures 20-23).
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Figure 20. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of ortho-substituted aromatic triethylene
glycol dithiol (11); (b) under standard conditions or 2 mM GSSG and various
concentrations of ortho-substituted aromatic triethylene glycol dithiol (11).(a) (●) 7 mM
GSH/2 mM GSSG (standard conditions), (■) 0.25 mM 11/0.2 mM GSSG, (♦) 0.50 mM
11/0.2 mM GSSG, (▼) 1.0 mM 11/0.2 mM GSSG, and (▲) 2.0 mM 11/0.2 mM GSSG;
(b) (●) 7 mM GSH/2 mM GSSG (standard conditions), (■) 0.25 mM 11/2 mM GSSG, (♦)
0.50 mM 11/2 mM GSSG, (▼) 1.0 mM 11/2 mM GSSG, and (▲) 2.0 mM 11/2 mM
GSSG.
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Figure 21. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of ortho-substituted aromatic triethylene
glycol dithiol (11); (b) under standard conditions or 2 mM GSSG and various
concentrations of ortho-substituted aromatic triethylene glycol dithiol (11). (a) (●) 7 mM
GSH/2 mM GSSG (standard conditions), (▼) 1 mM 11/0.2 mM GSSG, (▲) 2 mM
11/0.2 mM GSSG, () 4.0 mM 11/0.2 mM GSSG, and ()7.0 mM 11/0.2 mM GSSG;
(b) (●) 7 mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 11/2 mM GSSG, (▼)
1.0 mM 11/2 mM GSSG, (▲) 2.0 mM 11/2 mM GSSG, (Δ) 3.0 mM 11/2 mM GSSG,
and () 10.0 mM 11/2 mM GSSG.
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Figure 22. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of ortho-substituted aromatic tetraethylene
glycol dithiol (12); (b) under standard conditions or 2 mM GSSG and various
concentrations of ortho-substituted aromatic tetraethylene glycol dithiol (12). (a) (●) 7
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 12/0.2 mM GSSG, (▼) 1.0
mM 12/0.2 mM GSSG, (▲) 2.0 mM 12/0.2 mM GSSG, (Δ) 3.0 mM 12/0.2 mM GSSG
and () 10.0 mM 12/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard
conditions), (■) 0.25 mM 12/2 mM GSSG, (♦) 0.5 mM 12/2 mM GSSG, (▼) 1.0 mM
12/2 mM GSSG, (▲) 2.0 mM 12/2 mM GSSG, and (Δ) 3.0 mM 12/2 mM GSSG.
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Figure 23. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of ortho-substituted aromatic tetraethylene
glycol dithiol (12); (b) under standard conditions or 2 mM GSSG and various
concentrations of ortho-substituted aromatic tetraethylene glycol dithiol (12). (a) (●) 7
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 12/0.2 mM GSSG, (▼) 1.0
mM 12/0.2 mM GSSG, (▲) 2.0 mM 12/0.2 mM GSSG, (Δ) 3.0 mM 12/0.2 mM GSSG,
and () 10.0 mM 12/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard
conditions), (♦) 0.5 mM 12/2 mM GSSG, (▼) 1.0 mM 12/2 mM GSSG, (▲) 2.0 mM
12/2 mM GSSG, (Δ) 3.0 mM 12/2 mM GSSG, and () 10.0 mM 12/2 mM GSSG.
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Table 1. Folding of lysozyme with ortho-substituted aromatic triethylene glycol dithiol
(11) at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.25 mM 11/0.2 mM GSSG

66

0.013

0.9

0.5 mM 11/0.2 mM GSSG

55

0.002

0.1

1 mM 11/0.2 mM GSSG

20

0.004

0.1

2 mM 11/0.2 mM GSSG

19

0.001

0.0

0.25 mM 11/2 mM GSSG

26

0.015

0.4

0.5 mM 11/2 mM GSSG

43

0.012

0.5

1 mM 11/2 mM GSSG

63

0.013

0.8

2 mM 11/2 mM GSSG

62

0.016

0.9

7 mM GSH/2 mM GSSG

82

0.010

0.8

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

1 mM 11/0.2 mM GSSG

58

0.04

2.3

2 mM 11/0.2 mM GSSG

62

0.009

0.6

4 mM 11/0.2 mM GSSG

9

0.014

0.1

7 mM 11/0.2 mM GSSG

0

0.159

0.2

0.5 mM 11/2 mM GSSG

83

0.026

2.2

1 mM 11/2 mM GSSG

81

0.049

4.0

2 mM 11/2 mM GSSG

75

0.073

5.5

3 mM 11/2 mM GSSG

57

0.049

2.8

10 mM 11/2 mM GSSG

0

0.107

0.0

7 mM GSH/2 mM GSSG

84

0.050

4.2

The folding of lysozyme in the presence of aromatic dithiols (11 and 12) was
compared by fitting the data to a single exponential function. The exponential function
used was y =A(1- e

–kt

), where A is the maximal enzymatic activity achieved, k is the

apparent folding rate constant, and t is time. The initial folding rate corresponds to A*k.
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The A, k, and A*k values for ortho-substituted aromatic tri- and tetraethylene glycol
dithiols (11 and 12) are shown in Tables 1 and 2.
Table 2. Folding of lysozyme with ortho-substituted aromatic tetraethylene glycol dithiol
(12) at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 12/0.2 mM GSSG

85

0.008

0.7

1 mM 12/0.2 mM GSSG

62

0.009

0.5

2 mM 12/0.2 mM GSSG

30

0.007

0.2

3 mM 12/0.2 mM GSSG

2

0.010

0.02

10 mM 12/0.2 mM GSSG

0

0.190

0.3

0.25 mM 12/2 mM GSSG

45

0.004

0.2

0.5 mM 12/2 mM GSSG

60

0.005

0.3

1 mM 12/2 mM GSSG

69

0.007

0.5

2 mM 12/2 mM GSSG

69

0.012

0.8

3 mM 12/2 mM GSSG

84

0.01

0.8

7 mM GSH/2 mM GSSG

87

0.010

0.9

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 12/0.2 mM GSSG

76

0.061

4.7

1 mM 12/0.2 mM GSSG

62

0.052

3.2

2 mM 12/0.2 mM GSSG

45

0.028

1.3

3 mM 12/0.2 mM GSSG

27

0.023

0.6

10 mM 12/0.2 mM GSSG

0

0.322

0.5

0.5 mM 12/2 mM GSSG

81

0.018

1.5

1 mM 12/2 mM GSSG

69

0.068

4.7

2 mM 12/2 mM GSSG

55

0.072

4.0

3 mM 12/2 mM GSSG

45

0.065

3.0

10 mM 12/2 mM GSSG

1

0.299

0.4

7 mM GSH/2 mM GSSG

87

0.047

4.0
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4.2.1.5. Folding of lysozyme with para -series of aromatic ethylene glycol dithiols
(14 and 15)
Folding experiments with lysozyme using para-substituted aromatic tri- and
tetraethylene glycol dithiols (14 and 15) were also performed. In a similar manner as
ortho-substituted aromatic tri- and tetraethylene glycol dithiols (11and 12), a range of
concentrations was examined to find the best concentrations of dithiols 14 and 15. Unlike
dithiols 11 and 12, dithiols 14 and 15 were soluble ( >20 mM) in 0.1 M bis tris propaneHCl buffer (pH 7.0) and 0.1 M Tris-HCl buffer (pH 8.0). The concentrations of dithiols
14 and 15 examined were in the range of 0.5 to 10 mM at pH 7.0 and 8.0. Although
dithiols 14 and 15 were soluble in 0.1 M bis tris propane-HCl buffer (pH 7.0) and 0.1 M
Tris-HCl buffer (pH 8.0), concentrations above 10 mM were not used for folding studies
as the protein showed little or no activity at 10 mM. Folding experiments were carried out
using various concentrations of dithiols 14 and 15 in combination with either 0.2 or 2
mM GSSG at pH 7.0 and 8.0. (Tables 3 and 4, Figures 24-27). These folding experiments
were then done simultaneously with the standard conditions, 7 mM GSH and 2 mM
GSSG. The folding of lysozyme in the presence of dithiols 14 and 15 was then compared
by fitting the data to a single exponential function, y =A(1- e
values for dithiols 14 and 15 are shown in the tables 3 and 4.
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–kt

). The A, k, and A*k
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Figure 24. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of para-substituted aromatic triethylene glycol
dithiol (14); (b) under standard conditions or 2 mM GSSG and various concentrations of
para-substituted aromatic triethylene glycol dithiol (14). (a) (●) 7 mM GSH/2 mM GSSG
(standard conditions), (♦) 0.5 mM 14/0.2 mM GSSG, (▼) 1.0 mM 14/0.2 mM GSSG,
(▲) 2.0 mM 14/0.2 mM GSSG, (Δ) 3.0 mM 14/0.2 mM GSSG, and () 10.0 mM 14/0.2
mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 14/2
mM GSSG, (▼) 1.0 mM 14/2 mM GSSG, (▲) 2.0 mM 14/2 mM GSSG and (Δ) 3.0 mM
14/2 mM GSSG.
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Figure 25. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of para-substituted aromatic triethylene glycol
dithiol (14); (b) under standard conditions or 2 mM GSSG and various concentrations of
para-substituted aromatic triethylene glycol dithiol (14). (a) (●) 7 mM GSH/2 mM GSSG
(standard conditions), (♦) 0.5 mM 14/0.2 mM GSSG, (▼) 1.0 mM 14/0.2 mM GSSG,
(▲) 2.0 mM 14/0.2 mM GSSG, and (Δ) 3.0 mM 14/0.2 mM GSSG; (b) (●) 7 mM GSH/
2 mM GSSG (standard conditions), (♦) 0.5 mM 14/2 mM GSSG, (▼) 1.0 mM 14/2 mM
GSSG, (▲) 2.0 mM 14/2 mM GSSG and (Δ) 3.0 mM 14/2 mM GSSG.
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Figure 26. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of para-substituted aromatic tetraethylene
glycol dithiol (15); (b) under standard conditions or 2 mM GSSG and various
concentrations of para-substituted aromatic tetraethylene glycol dithiol (15). (a) (●) 7
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 15/0.2 mM GSSG, (▼) 1.0
mM 15/0.2 mM GSSG, (Δ) 3.0 mM 15/0.2 mM GSSG, and () 10.0 mM 15/0.2 mM
GSSG; (b (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 15/2 mM
GSSG, (▼) 1.0 mM 15/2 mM GSSG, (▲) 2.0 mM 15/2 mM GSSG, (Δ) 3.0 mM 15/2
mM GSSG, and () 10.0 mM 15/2 mM GSSG.
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Figure 27. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of para-substituted aromatic tetraethylene
glycol dithiol (15); (b) under standard conditions or 2 mM GSSG and various
concentrations of para-substituted aromatic tetraethylene glycol dithiol (15). (a) (●) 7
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 15/0.2 mM GSSG, (▼) 1.0
mM 15/0.2 mM GSSG, (▲) 2.0 mM 15/0.2 mM GSSG, and (Δ) 3.0 mM 15/0.2 mM
GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 15/2 mM
GSSG, (▼) 1.0 mM 15/2 mM GSSG, (▲) 2.0 mM 15/2 mM GSSG, (Δ) 3.0 mM 15/2
mM GSSG, and () 10.0 mM 15/2 mM GSSG.
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Table 3. Folding of lysozyme with para-substituted aromatic triethylene glycol dithiol
(14) at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 14/0.2 mM GSSG

57

0.025

1.4

1 mM 14/0.2 mM GSSG

50

0.028

1.4

2 mM 14/0.2 mM GSSG

36

0.024

0.9

3 mM 14/0.2 mM GSSG

23

0.020

0.5

10 mM 14/0.2 mM GSSG

0.5

0.058

0.03

0.5 mM 14/2 mM GSSG

41

0.012

0.5

1 mM 14/2 mM GSSG

44

0.019

0.9

2 mM 14/2 mM GSSG

40

0.032

1.3

3 mM 14/2 mM GSSG

34

0.035

1.2

7 mM GSH/2 mM GSSG

83

0.010

0.9

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 14/0.2 mM GSSG

63

0.076

4.8

1 mM 14/0.2 mM GSSG

51

0.082

4.2

2 mM 14/0.2 mM GSSG

31

0.088

2.7

3 mM 14/0.2 mM GSSG

16

0.103

1.6

0.5 mM 14/2 mM GSSG

61

0.036

22

1 mM 14/2 mM GSSG

43

0.069

3.0

2 mM 14/2 mM GSSG

16

0.285

4.5

3 mM 14/2 mM GSSG

2

0.820

1.5

7 mM GSH/2 mM GSSG

85

0.070

6.0

An increase in the overall yield of native protein with both series of aromatic dithiols (11,
12, 14, and 15) was expected, because of the presence of the second thiol group on the
aliphatic chain in comparison with 7 mM GSH and 2 mM GSSG. However, a general
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decreased in the overall yield of native protein with both series of aromatic dithiols (11,
12, 14, and 15) was observed.
Table 4. Folding of lysozyme with para-substituted aromatic tetraethylene glycol dithiol
(15) at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 15/0.2 mM GSSG

39

0.038

1.5

1 mM 15/0.2 mM GSSG

40

0.050

2.0

3 mM 15/0.2 mM GSSG

36

0.045

1.6

10 mM 15/0.2 mM GSSG

13

0.066

0.8

0.5 mM 15/2 mM GSSG

54

0.008

0.4

1 mM 15/2 mM GSSG

58

0.017

1.0

2 mM 15/2 mM GSSG

49

0.040

2.0

3 mM 15/2 mM GSSG

38

0.054

2.0

10 mM 15/2 mM GSSG

0

0.081

0.02

7 mM GSH/2 mM GSSG

83

0.011

0.9

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 15/0.2 mM GSSG

73

0.087

6.4

1 mM 15/0.2 mM GSSG

69

0.096

6.7

2 mM 15/0.2 mM GSSG

61

0.086

5.3

3 mM 15/0.2 mM GSSG

43

0.072

3.1

0.5 mM 15/2 mM GSSG

39

0.061

2.4

1 mM 15/2 mM GSSG

54

0.028

1.5

2 mM 15/2 mM GSSG

22

0.192

4.2

3 mM 15/2 mM GSSG

10

0.354

3.7

10 mM 15/2 mM GSSG

1

1.304

0.9

7 mM GSH/2 mM GSSG

86

0.064

5.6
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4.2.1.6 Synthesis and folding studies with para-substituted aromatic diethylene
glycol dithiol (13)

S S

S

S

S
S

O

O

O

O
O

O

O

Diethylene disulfide

O

O

O

Triethylene disulfide

O

O

Tetraethylene disulfide

Figure 28. Stable cyclic structure
After performing the folding experiments above, similar trends in terms of folding
yield with ortho- and para- series of aromatic dithiols (11, 12, 14, and 15) was observed.
I thought that the decrease in yield was as a result of the formation of stable cyclic
disulfides with 11, 12, 14, and 15 (Figure 28, stable disulfides shown only for 14 and 15).
In order to verify the hypothesis, para-substituted aromatic diethylene glycol dithiol (13)
was synthesized as shown in Scheme 10 and assumed that dithiol 13 may form a less
stable cyclic disulfide (Figure 28). Next, the folding studies with dithiol 13 was
performed. The concentrations of dithiol 13 examined were in the range of 0.5 to 10 mM.
The folding experiments were carried out in combination with either 0.2 or 2 mM GSSG
at pH 8.0. (Table 5, Figure 29). However, dithiol 13 showed similar trends as the orthoand para- derivatives of tri- and tetraethylene glycol dithiols (11, 12, 14, and 15). The
yield decreased with increasing concentrations of dithiol 13. Thus, the decreases in yield
may not be the result of the formation of a stable cyclic disulfide, but some other factor.
Next, the role of the thiol present on the aliphatic chain was investigated.
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Figure 29. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of para-substituted aromatic diethylene glycol
dithiol (13); (b) under standard conditions or 2 mM GSSG and various concentrations of
para-substituted aromatic diethylene glycol dithiol (13). (a) (●) 7 mM GSH/ 2 mM
GSSG (standard conditions), (♦) 0.5 mM 13/0.2 mM GSSG, (▼) 1.0 mM 13/0.2 mM
GSSG, (▲) 2.0 mM 13/0.2 mM GSSG, (Δ) 3.0 mM 13/0.2 mM GSSG, and () 10.0
mM 13/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5
mM 13/2 mM GSSG, (▼) 1.0 mM 13/2 mM GSSG, (▲) 2.0 mM 13/2 mM GSSG, (Δ)
3.0 mM 13/2 mM GSSG, and () 10.0 mM 13/2 mM GSSG.
Table 5. Folding of lysozyme with para-substituted aromatic diethylene glycol dithiol
(13) at pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 13/0.2 mM GSSG

53

0.072

3.79

1 mM 13/0.2 mM GSSG

36

0.066

2.39

2 mM 13/0.2 mM GSSG

21

0.065

1.33

3 mM 13/0.2 mM GSSG

9

0.08

0.71

10 mM 13/0.2 mM GSSG

0

0

0

0.5 mM 13/2 mM GSSG

53

0.023

1.21

1 mM 13/2 mM GSSG

35

0.055

1.89

2 mM 13/2 mM GSSG

14

0.131

1.79

3 mM 13/2 mM GSSG

1

2.849

4.06

10 mM 13/2 mM GSSG

0

0

0

7 mM GSH/2 mM GSSG

85

0.051

4.34
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4.2.1.7 Synthesis and folding studies with aromatic triethylene glycol monothiol (61)
To check the role of aliphatic thiol on the yield of lysozyme, aromatic triethylene
glycol monothiol (61) was synthesized, a compound with a thiol group on the aliphatic
chain and without a thiol group on the aromatic ring. Monothiol 61 was synthesized by
treating readily available benzoyl chloride (59) with triethylene glycol disulfide (38) in
the presence of triethylamine to give compound 60. Compound 60 was purified by
column chromatography and then reduced with DTT in the presence of triethylamine to
form monothiol 61 (Scheme 11).
O

HO

m

m=2
38
COCl

S
2

O
Et3N, CH2Cl2

O

O

14%

S
m

2

m=2
60

59

DTT, Et3N
CH2Cl2
57%

O

O

O

SH
m

m=2
61

Scheme 11. Synthesis of aromatic triethylene glycol monothiol (61)
Monothiol 61 was partially soluble in 0.1 M Trizma base buffer (pH 8.0), hence,
its solubility was determined by Ellman’s method.141 The solubility of monothiol 61 was
found to be 2 mM at pH 8.0. Thus, the concentrations of monothiol 61 examined were
0.25, 0.5, and 1 mM. The folding experiments were performed in the presence of either
0.2 or 2 mM GSSG at pH 8.0 (Table 6, Figure 30). Monothiol 61 showed not only a
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decrease in the yield but also a decrease in the rate as compared to 7 mM GSH/2 mM
GSSG.
100

% Activity
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60
40
20
0
0

50
100
Time (min)

150

Figure 30. Folding of lysozyme (0.1 mg/mL) at pH 8.0; under standard conditions or 0.2
mM GSSG and various concentrations of aromatic triethylene glycol monothiol (61) or 2
mM GSSG and various concentrations of aromatic triethylene glycol monothiol (61). (●)
7 mM GSH/ 2 mM GSSG (standard conditions), (■) 0.25 mM 61/0.2 mM GSSG, (♦) 0.5
mM 61/0.2 mM GSSG, (▼) 1.0 mM 61/0.2 mM GSSG, (▲) 0.25 mM 61/2 mM GSSG,
and (Δ) 0.5 mM 61/2 mM GSSG.
Table 6. Folding of lysozyme with aromatic triethylene glycol monothiol (61) at pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.25 mM 61/0.2 mM GSSG

68

0.028

1.9

0.5 mM 61/0.2 mM GSSG

49

0.019

1.0

1 mM 61/0.2 mM GSSG

2

0.012

0.02

0.25 mM 61/2 mM GSSG

65

0.019

1.3

0.5 mM 61/2 mM GSSG

54

0.034

1.9

7 mM GSH/2 mM GSSG

86

0.055

4.7

4.2.1.8 Folding studies with triethylene glycol monothiol (36)
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Figure 31. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or
0.2 mM GSSG and various concentrations of triethylene glycol monothiol (36); (b) under
standard conditions or 2 mM GSSG and various concentrations of triethylene glycol
monothiol (36). (a) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM
36/0.2 mM GSSG, (▼) 1.0 mM 36/0.2 mM GSSG, (▲) 2.0 mM 36/0.2 mM GSSG, (Δ)
3.0 mM 36/0.2 mM GSSG, and () 10.0 mM 36/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2
mM GSSG (standard conditions), (♦) 0.5 mM 36/2 mM GSSG, (▼) 1.0 mM 36/2 mM
GSSG, (▲) 2.0 mM 36/2 mM GSSG, (Δ) 3.0 mM 36/2 mM GSSG, and () 10.0 mM
36/2 mM GSSG.
Table 7. Folding of lysozyme with triethylene glycol monothiol (36) at pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

0.5 mM 36/0.2 mM GSSG

72

0.027

1.92

1 mM 36/0.2 mM GSSG

72

0.029

2.08

2 mM 36/0.2 mM GSSG

77

0.025

1.88

3 mM 36/0.2 mM GSSG

68

0.024

1.60

10 mM 36/0.2 mM GSSG

53

0.008

0.43

0.5 mM 36/2 mM GSSG

58

0.018

1.0

1 mM 36/2 mM GSSG

72

0.020

1.5

2 mM 36/2 mM GSSG

71

0.034

2.5

3 mM 36/2 mM GSSG

75

0.037

2.8

10 mM 36/2 mM GSSG

77

0.036

2.8

7 mM GSH/2 mM GSSG

80

0.053

4.3

Finally, folding experiments with triethylene glycol monothiol (36), a compound
without an aromatic ring were performed. Monothiol 36 was synthesized as shown in
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Scheme 7. Folding experiments were performed at pH 8.0, using various concentrations
of monothiol 36 in combination with either 0.2 or 2 mM GSSG (Table 7, Figure 31).
Folding results with monothiol 36 showed similar folding yields and slightly lower
folding rates as compared to GSH/GSSG, indicating similar behavior for both aliphatic
thiols. The slower folding rate with monothiol 36 as compared to GSH may be because of
the lower thiol pKa of monothiol 36 than that of the GSH.
In summary, ortho- and para-substituted aromatic ethylene glycol dithiols (11,
12, 14, and 15) showed a decrease in the yield of native lysozyme relative to the
traditional conditions of GSH and GSSG. The initial hypothesis to explain the decrease in
yield was that dithiols 11, 12, 14, and 15 may form stable cyclic disulfides. To test the
hypothesis, para-substituted aromatic diethylene glycol dithiol (13) was synthesized and
examined for its ability to fold reduced lysozyme. However, the initial hypothesis was
not substantiated as dithiol 13 showed similar results in terms of yield as dithiols 11, 12,
14, and 15. Next, the role of the aliphatic thiol on the folding rate and yield of lysozyme
was investigated. To check the role of aliphatic thiol, two compounds were synthesized,
an aromatic triethylene glycol monothiol (61), a compound with a thiol on the aliphatic
chain and without a thiol on the aromatic ring, and triethylene glycol monothiol (36).
Both compounds (61 and 36) were then examined for their ability to fold reduced
lysozyme. Monothiol 61 decreased the folding rate as well as yield of lysozyme. On the
contrary, monothiol 36 showed similar results as GSH/GSSG. Thus, an aliphatic thiol
group without an aromatic ring does not have any effect on the yield, whereas a thiol
group on an aliphatic chain attached to an aromatic ring decreases the yield. To conclude,
the decrease in the yield of native lysozyme with ortho- and para-substituted aromatic
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ethylene glycol dithiols (11, 12, 14, and 15) may be because of the presence of the thiol
group on an aliphatic chain attached to an aromatic ring.
4.3 Di Quaternary ammonium aromatic dithiols (16 and 17)
In the first series of aromatic dithiols (ortho- and para-series), one thiol group
was present on the aromatic ring and a second thiol group was present on the aliphatic
chain. The results of the folding experiments with ortho- and para-substituted aromatic
ethylene glycol dithiols (11, 12, 14, and 15) showed a decrease in the in vitro folding rate
and yield as compared to standard conditions. Thus, a new series of aromatic dithiols
were designed which should improve the in vitro folding rate and yield of lysozyme. The
new series of aromatic dithiols were designed on the basis of a previously synthesized
aromatic quaternary ammonium salt monothiol (Mono QAS) (3). Mono QAS 3 increased
the folding rate and yield of reduced lysozyme (0.1 mg/mL as well at 1 mg/mL).37,38
Hence, new aromatic dithiols (16 and 17) similar in structure to the Mono QAS 3 were
designed, having one thiol group on each of the two aromatic rings and the two aromatic
rings connected by a hydrocarbon chain containing two quaternary ammonium groups.
The criteria for selecting aromatic di quaternary ammonium salt dithiols (Di QAS) (16
and 17) were water solubility and low thiol pKa values, the same criteria as those used for
dithiols 11, 12, 14, and 15. Furthermore, Di QAS 16 and Di QAS 17 were compared with
Mono QAS 3 to check the effect of the second thiol group on folding rate and yield of a
disulfide containing protein.
4.3.1 Synthesis of aromatic di quaternary ammonium salt dithiols (16 and 17)
Next, Di QAS 16 and Di QAS 17 were synthesized from brominated compound
(25) in two simple steps, a coupling reaction followed by a hydrolysis reaction. The
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brominated compound (25) was synthesis as shown in Scheme 4. The brominated
compound (25) was treated with N,N,N',N'-tetramethyl-1,3-propane diamine (63) or
N,N,N',N'-tetramethyl-1,6-hexane diamine (65) to form compound (67) and (69),
respectively. Compounds (67) and (69) were then hydrolyzed with 1:1 HBr:H2O at 130
o

C for 90 min to give Di QAS 16 and Di QAS 17, respectively, (Scheme 12).
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Scheme 12. Synthesis of aromatic di quaternary ammonium salt dithiols (16 and 17)

4.3.2 Folding of lysozyme with Di QAS (16 and 17)
Di QAS 16 and Di QAS 17 in various concentrations along with 2 mM GSSG
were utilized for the folding of reduced lysozyme (0.1 mg/mL) at pH 7.0 and 8.0. These
folding experiments were conducted simultaneously with the standard condition, 7 mM
GSH and 2 mM GSSG. The folding of lysozyme was followed using the recovery of
enzymatic activity as described for the dithiols 11, 12, 14, and 15. Initially, folding of
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Table 8. Folding of lysozyme (0.1 mg/mL) with DI QAS 16 and GSH at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

1 mM 16/2 mM GSSG

87

0.010

0.9

2 mM 16/2mM GSSG

84

0.016

1.4

3 mM 16/2 mM GSSG

87

0.025

2.2

7 mM 16/2 mM GSSG

75

0.042

3.2

10 mM 16/2 mM GSSG

58

0.1

5.8

7 mM GSH/2 mM GSSG

91

0.007

0.6

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

1 mM 16/2 mM GSSG

94

0.013

1.2

2 mM 16/2mM GSSG

98

0.006

0.6

3 mM 16/2 mM GSSG

92

0.018

1.7

7 mM 16/2 mM GSSG

85

0.034

2.9

10 mM 16/2 mM GSSG

61

0.065

4.0

7 mM GSH/2 mM GSSG

90

0.045

4.0

reduced lysozyme was performed using 1, 2, 3, 7, and 10 mM Di QAS 16 or Di QAS 17
in the presence of 2 mM GSSG at pH 7.0 and 8.0. Both Di QAS 16 and Di QAS 17 were
soluble ( >100 mM) in 0.1 M bis tris propane-HCl buffer (pH 7.0) and 0.1 M Tris-HCl
buffer (pH 8.0). The folding of lysozyme in the presence of Di QAS 16 and Di QAS 17
was compared by fitting the data to a single exponential function [y =A(1- e –kt)], similar
to that used for the dithiols 11, 12, 14, and 15 (Tables 8 and 9). Preliminary studies
suggested that at pH 7.0, Di QAS 16 and Di QAS 17 increased the folding rate
significantly with increasing concentration as compared to GSH/GSSG. However, at pH
8.0, below 7 mM Di QAS 16 and below 3 mM of Di QAS 17 the folding rate was slower,
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while at 10 mM of Di QAS 16 and above 7 mM Di QAS 17 the folding rate was
significantly faster as compared to GSH/GSSG. At pH 7.0 and 8.0, Di QAS 17 showed
similar yields of native lysozyme at all concentrations as GSH/GSSG. However, with Di
QAS 16 at both pH 7.0 and 8.0, the folding yield decreased with increasing concentration
as compared to GSH/GSSG.
Table 9. Folding of lysozyme (0.1 mg/mL) with DI QAS 17 and GSH at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

1 mM 17/2 mM GSSG

73

0.013

0.9

2 mM 17/2mM GSSG

71

0.028

2.0

3 mM 17/2 mM GSSG

73

0.034

2.4

7 mM 17/2 mM GSSG

72

0.067

4.8

10 mM 17/2 mM GSSG

68

0.081

5.5

7 mM GSH/2 mM GSSG

67

0.008

0.6

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

1 mM 17/2 mM GSSG

68

0.013

0.9

2 mM 17/2mM GSSG

78

0.020

1.6

3 mM 17/2 mM GSSG

78

0.030

2.2

7 mM 17/2 mM GSSG

72

0.064

4.6

10 mM 17/2 mM GSSG

73

0.083

6.0

7 mM GSH/2 mM GSSG

72

0.040

2.9

Next, folding experiments at high lysozyme concentration (1 mg/mL) using Di
QAS 16 and Di QAS 17 at pH 7.0 and 8.0 were performed. Preliminary studies were
performed to find the best concentration of Di QAS 16, Di QAS 17, and GSSG at both
pH 7.0 and 8.0. Herein, GSSG was selected instead of the respective aromatic disulfides,
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as the aromatic disulfides were partially soluble in the 0.1 M bis tris propane-HCl buffer
(pH 7.0) and 0.1 M Tris-HCl buffer (pH 8.0). Herein, the concentrations of Di QAS 16
and Di QAS 17 screened were 10, 20, 40, 70, and 100 mM, and the concentrations of
GSSG examined were 0.5, 1, and 2 mM. In addition, the concentrations of Di QAS 16
examined with 2 mM GSSG were 1, 2, 3, 7, and 10 mM. Concentrations of Di QAS 16
and Di QAS 17 were selected to screen a wide range of concentrations. At pH 7.0 and
8.0, the two best combinations of each of Di QAS 16/GSSG and Di QAS 17/GSSG were
selected. At pH 7.0, the best concentration pairs for Di QAS 16 were 10 mM 16/1 mM
GSSG and 20 mM 16/1 mM GSSG whereas at pH 8.0, the best concentration pairs were
20 mM 16/1 mM GSSG and 40 mM 16/1 mM GSSG. On the other hand at pH 7.0, the
best concentration pairs for Di QAS 17 were found to be 10 mM 17/0.5 mM GSSG and
10 mM 17/1 mM GSSG whereas at pH 8.0, the best pairs were 10 mM 17/1 mM GSSG
and 20 mM 17/1 mM GSSG.
To investigate the effect of the second thiol group on the folding rates and yields
of reduced lysozyme, folding studies with Di QAS 16 and Di QAS 17 were performed
simultaneously with Mono QAS 3. Folding of reduced lysozyme with various
concentrations of Mono QAS 3 and various concentrations of GSSG were performed at
both pH 7.0 and 8.0 to find the best combination of Mono QAS 3/GSSG. Herein, the
concentrations of Mono QAS 3 selected were 10, 20, 40, 70, and 100 mM and the
concentrations of GSSG selected were 0.5, 1, and 2 mM. The best combination pair at pH
7.0 and 8.0 was found to be 40 mM 3/1 mM GSSG.
Next, comparative folding studies with the best combination pairs of Di QAS
16/GSSG, Di QAS 17/GSSG and Mono QAS 3/GSSG were conducted simultaneously
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with 7 mM GSH/2 mM GSSG at both pH 7.0 and 8.0 (Figure 32) The data were fit to a
single exponential function, y = A(1- e –kt). The concentration of thiol which provided the
highest value of the initial folding rate, A*k, was defined as optimal. The A, k, and A*k
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Figure 32. Folding of lysozyme (1 mg/mL) : (a) at pH 7.0, (●) 7 mM GSH/ 2 mM GSSG
(standard conditions), (■) 40 mM 3/1 mM GSSG, (♦) 10 mM 16/1 mM GSSG, (▼) 20
mM 16/1 mM GSSG, (▲) 10 mM 17/0.5 mM GSSG, and (Δ) 10.0 mM 17/1 mM GSSG;
(b) at pH 8.0, (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (■) 40 mM 3/1 mM
GSSG, (▼) 20 mM 16/1 mM GSSG, () 40 mM 16/1 mM GSSG, (Δ) 10 mM 17/1 mM
GSSG, and () 20.0 mM 17/1 mM GSSG.
values at pH 7.0 and 8.0 are shown in the table 10. The results indicate a significant
increase in the folding rate and yields for aromatic monothiol 3/GSSG, dithiol 16/GSSG,
and dithiol 17/GSSG relative to GSH/GSSG at pH 7.0. The folding rate increase from 11
to 17 times and the yields increase from 26 to 42% relative to GSH/GSSG. The best
folding rate was observed with 40 mM 3/1 mM GSSG, whereas the best yield was
observed with 20 mM 16/1 mM GSSG. While comparing aromatic dithiols versus
aromatic monothiols, aromatic monothiol (40 mM 3/1 mM GSSG) showed a significant
increase in folding rate as compared to aromatic dithiols (10 mM 16/1 mM GSSG and 20
mM 16/1 mM GSSG). However, aromatic dithiol (20 mM 16/1 mM GSSG) significantly
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increase the yield of native lysozyme as compared to aromatic monothiol (40 mM 3/1
mM GSSG). The A*k values illustrate that best combination of aromatic thiol/GSSG
concentrations at pH 7.0 were 40 mM 3/1 mM GSSG and 20 mM 16/1 mM GSSG. The
A*k values for 40 mM 3/1 mM GSSG and 20 mM 16/1 mM GSSG were 28 and 24
times, respectively, greater than that of GSH/GSSG at pH 7.0 and a protein concentration
of 1 mg/mL.
Table 10. Folding of lysozyme (1 mg/mL) with Mono QAS 3, Di QAS 16, Di QAS 17,
and GSH at pH 7.0 and 8.0
pH 7.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

40 mM 3/1 mM GSSG

82 ± 3

0.017 ± 0.002

1.4 ± 0.2

10 mM 16/1 mM GSSG

83 ± 5

0.012 ± 0.001

1.0 ± 0.2

20 mM 16/1 mM GSSG

86 ± 4

0.015 ± 0.003

1.2 ± 0.3

10 mM 17/0.5 mM GSSG

70 ± 5

0.013 ± 0.002

0.9 ± 0.2

10 mM 17/1 mM GSSG

74 ± 6

0.011 ± 0.001

0.8 ± 0.2

7 mM GSH/2 mM GSSG

44 ± 2

0.001 ± 0.0002

0.05 ± 0.01

pH 8.0
Redox buffer

A (%)

k (min -1)

A*k (%/min)

40 mM 3/1 mM GSSG

81 ± 6

0.018 ± 0.002

1.5 ± 0.1

20 mM 16/1 mM GSSG

88 ± 5

0.022 ± 0.003

2.0 ± 0.3

40 mM 16/1 mM GSSG

77 ± 10

0.023 ± 0.010

1.9 ± 1.0

10 mM 17/1 mM GSSG

78 ± 6

0.016 ± 0.002

1.3 ± 0.2

20 mM 17/1 mM GSSG

49 ± 26

0.017 ± 0.002

0.8 ± 0.4

7 mM GSH/2 mM GSSG

73 ± 4

0.003 ± 0.001

0.19 ± 0.02

At pH 8.0, Figure 32 illustrates a substantial increase in the folding rate and yield
with an Mono QAS 3 and Di QAS 16 as compared to GSH/GSSG (Table 10). The yield
improvements were as much as 15%, with the best being 20 mM 16/1 mM GSSG. The
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folding rates with Mono QAS 3 and Di QAS 16 were increased up to eight times
compared with 7 mM GSH/2 mM GSSG, the best being 40 mM 16/1 mM GSSG.
Comparison of aromatic monothiol (Mono QAS 3) versus aromatic dithiol (Di QAS 16)
at pH 8.0, revealed that Di QAS 16 were better than Mono QAS 3 in terms of rate and
yield. Aromatic dithiol (40 mM 16/1 mM GSSG) was better than aromatic monothiol (40
mM 3/1 mM GSSG) in terms of folding rate, whereas aromatic dithiol (20 mM 16/1 mM
GSSG) showed significant increase in yield as compared to aromatic monothiol (40 mM
3/1 mM GSSG). Overall, aromatic dithiol (20 mM 16/1 mM GSSG) was significantly
better in terms of rate and yield as compared to aromatic monothiol (40 mM 3/1 mM
GSSG). At higher concentration of Di QAS 17, 20 mM 17/1 mM GSSG, although the
rate was 6 times better than that of GSH/GSSG, the yield went down significantly. The
decrease in the yield with 20 mM 17/1 mM GSSG was because of precipitation of the
protein as seen by the naked eye. At pH 8.0 and a protein concentration of 1 mg/mL, 20
mM 16/1 mM GSSG and 40 mM 16/1 mM GSSG showed as much as 10 times better A*k
relative to 7 mM GSH/2 mM GSSG.
4.4 pKa Values of aromatic monothiols and aromatic dithiols
The pKa values of aromatic monothiols and aromatic dithiols were determined by
measuring the change in the UV-vis spectra as a function of pH. Buffers with pH values
within 1.5 units of the predicted pKa values of the thiol were selected. The UV-vis
spectrum of the thiol in each buffer was then obtained. The absorbance values at max of
either thiol or thiolate were then plotted against buffer pH and the resulting curve were
analyzed by numerical analysis. The thiol pKa values of the ortho-substituted aromatic
dithiols as well as triethylene aromatic monothiol were in the range of 6.8 to 7.2 (Table
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11, Figure 34). The thiol pKa values of the para-substituted aromatic dithiols as well as
Di QAS aromatic dithiols were in the range of 5.3 to 5.5 (Table 11, Figure 33). Figure 34
illustrates UV-vis spectra of para-substituted aromatic tetraethylene glycol dithiol (15) in
various pH buffers.
Table 11. pKa Values of aromatic monothiols and aromatic dithiols
Compound

Substitution

pKa

Diethylene glycol dithiol (ortho)
10
Triethylene glycol
dithiol (ortho) 11
Tetraethylene glycol dithiol
(ortho) 12
Diethylene glycol
dithiol (para) 13
Tetraethylene glycol
dithiol (para) 15
Mono QAS (para) 3
Di QAS (para) 16

o-HSPhCO2(CH2)2O(CH2)2SH

7.1

o-HSPhCO2(CH2CH2O)2CH2CH2SH

7.2

o-HSPhCO2(CH2CH2O)3CH2CH2SH

7.0

p-HSPhCO2(CH2)2O(CH2)2SH

5.4

p-HSPhCO2(CH2CH2O)3CH2CH2SH

5.5

p-HSPhCH2N+(CH3)3
p-HSPhCH2N+(CH3)2(CH2)3N+(CH3)2CH2-pPhSH
+
p-HSPhCH2N (CH3)2(CH2)6N+(CH3)2CH2-pPhSH

5.4
5.3

Di QAS (para) 17

2

2
(b) Triethylene dithiol ( ortho) 11
Absorbance

Absorbance

(a) Diethylene dithiol ( ortho) 10

1

0

5.4

4

6

8

1

0

10

pH

4

6

8
pH
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10

2

2
(d) Diethylene dithiol ( para ) 13
Absorbance

Absorbance

(c) Tetraethylene dithiol ( ortho ) 12

1

0

4

6

8

1

0

10

2

4

pH

2

2
Absorbance

Absorbance

1

2

4

6

0

8

2

4

8

6

8

pH

2

2
(h) Di QAS 17
Absorbance

(g) Di QAS 16
Absorbance

6

1

pH

1

0

8

(f) Mono QAS 3

(e) Tetraethylene dithiol ( para ) 15

0

6
pH

2

4

6

1

0

8

pH

2

4
pH

Figure 33. Determination of pKa values a) diethylene glycol dithiol (ortho) 10, b)
triethylene glycol dithiol (ortho) 11, c) tetraethylene glycol dithiol ortho 12, d) diethylene
glycol dithiol (para) 13, e) tetraethylene glycol dithiol (para) 15, f) Mono QAS 3, g) Di
QAS 16, h) Di QAS 17.
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Figure 34. UV-vis spectra of para-substituted aromatic tetraethylene glycol dithiol (15)
in various pH buffers.
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Chapter 5

Conclusion
Project 1
1)

Aromatic

monothiols,

such

mercaptobenzylphosphonic acid (2),

as

4-mercaptobenzoic

quaternary

acid

ammonium salt

(3),

(1),

4-

and 4-

mercaptobenzenesulfonic acid (4), and their corresponding disulfides (5-8) were
synthesized on a multigram scale.
2) Disulfides of 4-mercaptobenzylphosphonic acid (6), quaternary ammonium salt (7),
and 4-mercaptobenzenesulfonic acid (8) were utilized by Ms. Shweta Mandumula to fold
BPTI, in particular N* to N. The results demonstrated that small molecule aromatic
disulfides increase the folding rate constant of N* to N by 100-3000 fold as compared to
GSSG. Additionally, the results showed that N* does undergo direct oxidation to N,
which was proposed earlier by Kim and Creighton not to occur.
3) The 4-Mercaptobenzylphosphonic acid (2), quaternary ammonium salt (3), and their
corresponding disulfides (6 and 7) were utilized by Dr. David Madar to fold lysozyme at
high protein concentration (1 mg/mL). The results revealed that aromatic thiols increase
the folding rate up to 11 times and improve the yield between 20 and 40% as compared to
GSH/GSSG at pH 7.0. Furthermore, at pH 8.0, the folding rate was increased up to 7
times and the yield was improved up to 25% as compared to GSH/GSSG.
4) The disulfide of 4-mercaptobenzoic acid (5) was used to synthesize a series of parasubstituted aromatic ethylene glycol dithiols (13-15).
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Project 2
5) Two series of ortho- and para-substituted aromatic ethylene glycol dithiols (9-15)
were synthesized. Dithiols (11-15) were then checked for effect on the folding of
lysozyme at pH 7.0 and 8.0. The ortho- and para-substituted aromatic ethylene glycol
dithiols (11-15) showed a decrease in yield at both pH 7.0 and 8.0 as compared to
GSH/GSSG. The decrease in yield of native lysozyme may be because of the presence of
a thiol group on an aliphatic chain attached to an aromatic ring.

Project 3
6) Finally, Di QAS 16 and Di QAS 17 were synthesized on a multigram scale in two easy
steps from brominated intermediate (25) without any purification step except extraction.
7) Mono QAS 3, Di QAS 16, and Di QAS 17 were then tested for their ability to fold
lysozyme at high protein concentration (1 mg/mL) at both pH 7.0 and 8.0.
At pH 7.0, Mono QAS 3, Di QAS 16, and Di QAS 17 increased the folding rate
and yield from 11 to 17 times and 26 to 42%, respectively, relative to GSH/GSSG. While
comparing aromatic dithiols versus aromatic monothiols, aromatic monothiol (40 mM 3/1
mM GSSG) showed a significant increase in folding rate as compared to aromatic
dithiols (10 mM 16/1 mM GSSG and 20 mM 16/1 mM GSSG). However, aromatic dithol
(20 mM 16/1 mM GSSG) significantly increase the yield of native lysozyme as compared
to aromatic monothiol (40 mM 3/1 mM GSSG).
At pH 8.0, with Mono QAS (3), Di QAS 16, and Di QAS 17, the yield
improvements were as much as 15%, while the folding rate enhancements were up to 8
times compared to GSH/GSSG. Comparison of aromatic monothiol versus aromatic
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dithiols revealed that aromatic dithiol (16) was better than aromatic monothiol (3) in
terms of rate and yield. Aromatic dithiol (40 mM 16/1 mM GSSG) was better than
aromatic monothiol (40 mM 3/1 mM GSSG) in terms of folding rate, whereas aromatic
dithiol (20 mM 16/1 mM GSSG) showed a significant increase in yield as compared to
aromatic monothiol (40 mM 3/1 mM GSSG). Overall, aromatic dithiol (16) was
significantly better in terms of rate and yield as compared to aromatic monothiol (3).
8) In conclusion, Di QAS (aromatic dithiol) significantly increase the in vitro folding
yield of lysozyme as compared to Mono QAS (aromatic monothiol) at both pH 7.0 and
8.0 and high protein concentration (1 mg/mL). Moreover, Di QAS (aromatic dithiol) and
Mono QAS (aromatic monothiol) are better than aliphatic thiol such as glutathione in
terms of folding rate and yield at both pH 7.0 and 8.0 and high protein concentration (1
mg/mL). Thus, enhancement of the folding rate and yield achieved in in vitro protein
folding at high protein concentration will decrease the volume of renaturation solution
required for large scale processes and consequently reduce the processing time and cost.
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